setID	setSize	setScore	N	setP	setQ	setName	setID.orig
777	64	45.1467375305503	64	1e-04	0.126075	Collagen biosynthesis and modifying enzymes	306
780	87	51.8093372430817	87	2e-04	0.126075	Collagen formation	309
778	44	34.3199887753492	44	3e-04	0.126075	Collagen chain trimerization	307
1318	18	19.9462539139089	18	3e-04	0.126075	Other semaphorin interactions	1119
924	282	88.1121836942247	282	0.0011	0.351481818181818	Extracellular matrix organization	516
360	85	67.2324856516599	85	0.0013	0.351481818181818	Ribosome biogenesis in eukaryotes	1416
359	144	66.5818038221128	144	0.0018	0.351481818181818	Ribosome	1415
677	57	33.6679249290859	57	0.0019	0.351481818181818	Assembly of collagen fibrils and other multimeric structures	137
1178	20	18.8751633042286	20	0.0021	0.351481818181818	MET activates PTK2 signaling	927
86	10	12.8473101560861	9	0.0022	0.351481818181818	Polyomavirus (dsDNA)	1228
293	12	13.0446459949497	12	0.0023	0.351481818181818	Non-homologous end-joining	1066
1154	25	20.5831801290784	25	0.0026	0.364216666666667	Laminin interactions	869
120	43	25.8417592187246	43	0.0046	0.593953333333333	Arginine and proline metabolism	131
998	422	102.381264422941	422	0.0053	0.593953333333333	GPCR ligand binding	682
1275	10	10.7689243997134	10	0.0053	0.593953333333333	Netrin mediated repulsion signals	1041
146	130	50.2116202032322	130	0.0063	0.601621052631579	Cell adhesion molecules (CAMs)	241
526	37	20.5383323752991	37	0.0065	0.601621052631579	Regulation of RAC1 activity	1356
1546	128	42.9097202622795	128	0.0066	0.601621052631579	Rho GTPase cycle	1402
560	31	18.9584379733324	31	0.0068	0.601621052631579	Syndecan-4-mediated signaling events	1641
174	80	33.6199222204948	80	0.0078	0.65559	ECM-receptor interaction	458
111	91	36.5371469312167	91	0.0084	0.6724	Amoebiasis	92
771	39	34.141126877645	39	0.0088	0.6724	Class C/3 (Metabotropic glutamate/pheromone receptors)	295
477	26	16.0247469653079	26	0.0105	0.700416666666667	Glypican 1 network	676
366	61	26.8262321773095	61	0.0112	0.700416666666667	Shigellosis	1499
577	31	18.1405300323103	31	0.0113	0.700416666666667	a6b1 and a6b4 Integrin signaling	6
1181	31	18.1804731493513	31	0.0119	0.700416666666667	MET promotes cell motility	930
1257	54	23.8588921080644	54	0.0128	0.700416666666667	NRAGE signals death through JNK	1084
406	117	40.0024005175349	117	0.0129	0.700416666666667	Vascular smooth muscle contraction	1831
1670	19	13.2760588993348	19	0.0129	0.700416666666667	Syndecan interactions	1637
1221	21	14.0188577406738	21	0.0134	0.700416666666667	Mitochondrial tRNA aminoacylation	975
1587	64	26.0895668384434	64	0.0136	0.700416666666667	Semaphorin interactions	1485
685	519	93.6989777364224	519	0.014	0.700416666666667	Axon guidance (REACTOME)	162
176	46	21.5742153663836	46	0.0144	0.700416666666667	Endocrine and other factor-regulated calcium reabsorption	468
336	84	31.9402853552237	84	0.0144	0.700416666666667	Protein digestion and absorption	1268
1572	14	11.151715386912	14	0.0148	0.700416666666667	STING mediated induction of host immune responses	1611
527	42	20.380309661837	42	0.015	0.700416666666667	Regulation of RhoA activity	1359
130	74	28.3730601741052	74	0.0166	0.742767441860465	Bacterial invasion of epithelial cells	165
1668	27	17.3253871533567	27	0.0168	0.742767441860465	Surfactant metabolism	1634
550	52	22.033220393864	52	0.0174	0.742767441860465	Signaling events mediated by focal adhesion kinase	1563
169	86	30.9273698150056	86	0.0184	0.742767441860465	Dilated cardiomyopathy	404
913	11	11.4817704350872	11	0.0186	0.742767441860465	Endosomal/Vacuolar pathway	474
413	25	19.5267699644105	25	0.0188	0.742767441860465	alpha-Linolenic acid metabolism	81
195	190	47.8094646374032	190	0.019	0.742767441860465	Focal adhesion	559
578	48	20.7206471883808	48	0.0224	0.807389393939394	amb2 Integrin signaling	84
243	96	31.667401068578	96	0.0239	0.807389393939394	Inflammatory mediator regulation of TRP channels	787
325	120	37.0341998858397	120	0.024	0.807389393939394	Platelet activation	1213
43	10	8.14594124050893	10	0.0243	0.807389393939394	reactive oxygen species degradation	1310
711	11	8.72974369201773	11	0.0245	0.807389393939394	CD28 dependent Vav1 pathway	232
1814	619	97.9969742198319	619	0.0248	0.807389393939394	Vesicle-mediated transport	1840
1287	43	19.4474619671339	43	0.0253	0.807389393939394	Non-integrin membrane-ECM interactions	1067
178	244	53.725650762125	244	0.0255	0.807389393939394	Endocytosis	470
1316	10	10.0600185737253	10	0.0258	0.807389393939394	Organic cation transport	1114
1260	18	13.2195695707594	18	0.0259	0.807389393939394	Na+/Cl- dependent neurotransmitter transporters	1019
945	19	11.6774717607785	19	0.0263	0.807389393939394	FRS-mediated FGFR3 signaling	583
1560	17	11.0902812852241	17	0.0267	0.807389393939394	SHC-mediated cascade:FGFR3	1494
973	234	58.8123956403584	234	0.0269	0.807389393939394	G alpha (i) signalling events	588
1376	13	9.65000276619415	13	0.0275	0.807389393939394	Platelet Adhesion to exposed collagen	1215
482	11	8.63175867933826	11	0.0279	0.807389393939394	Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	761
1362	103	36.5540044362172	103	0.0293	0.807389393939394	Phase 1 - Functionalization of compounds	1173
478	64	22.8201049846898	64	0.0297	0.807389393939394	HIF-1-alpha transcription factor network	725
552	38	16.6470223004008	38	0.0297	0.807389393939394	Signaling events regulated by Ret tyrosine kinase	1574
1797	11	9.38428157418989	11	0.0305	0.807389393939394	Type I hemidesmosome assembly	1808
266	19	11.5108147764568	19	0.0308	0.807389393939394	Mannose type O-glycan biosynthesis	906
561	55	20.9592302567233	55	0.0313	0.807389393939394	TCR signaling in naive CD4+ T cells	1680
645	18	13.9871582075433	18	0.0315	0.807389393939394	Acyl chain remodelling of PG	50
995	19	11.7632825767236	19	0.0317	0.807389393939394	GABA synthesis, release, reuptake and degradation	610
646	17	13.7210076965532	17	0.0332	0.808649473684211	Acyl chain remodelling of PI	51
240	80	26.5154966619964	80	0.0339	0.808649473684211	Hypertrophic cardiomyopathy (HCM)	760
662	24	14.4058706382572	24	0.0346	0.808649473684211	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	102
310	93	30.5415990083829	93	0.0351	0.808649473684211	Pancreatic secretion	1143
904	13	9.08124161627451	13	0.0357	0.808649473684211	ERKs are inactivated	506
563	50	19.5817264495018	50	0.0358	0.808649473684211	TGF-beta receptor signaling	1689
1083	12	8.66448832997232	12	0.0362	0.808649473684211	IRF3-mediated induction of type I IFN	848
257	56	21.7172104291846	56	0.0364	0.808649473684211	Long-term depression	888
1640	39	16.7810414254884	39	0.0364	0.808649473684211	Signaling by Retinoic Acid	1553
872	13	9.18921911034136	13	0.0366	0.808649473684211	Dissolution of Fibrin Clot	417
1176	86	27.4318278521056	86	0.0371	0.808649473684211	MAPK6/MAPK4 signaling	915
231	90	31.4169559704078	90	0.0389	0.808649473684211	Hematopoietic cell lineage	707
414	30	14.8130047116139	30	0.0412	0.808649473684211	beta-Alanine metabolism	176
745	69	22.7618032890762	69	0.0412	0.808649473684211	Cell death signalling via NRAGE, NRIF and NADE	246
851	108	32.5809722879911	108	0.0412	0.808649473684211	Degradation of the extracellular matrix	391
890	55	20.4053040504855	55	0.0417	0.808649473684211	ECM proteoglycans	457
1434	34	15.3316752963368	34	0.0417	0.808649473684211	RHO GTPases Activate WASPs and WAVEs	1412
899	78	25.961031026206	78	0.0422	0.808649473684211	ER-Phagosome pathway	496
383	79	29.8143987150646	79	0.0423	0.808649473684211	Taste transduction	1672
256	29	17.4037025799685	29	0.0425	0.808649473684211	Linoleic acid metabolism	882
503	30	13.6846051369281	30	0.0434	0.808649473684211	Lissencephaly gene (LIS1) in neuronal migration and development	885
724	15	9.00247875236248	15	0.0445	0.808649473684211	CRMPs in Sema3A signaling	338
769	295	58.0754556772711	295	0.0451	0.808649473684211	Class A/1 (Rhodopsin-like receptors)	293
951	230	46.8938848682806	230	0.0451	0.808649473684211	Fatty acid, triacylglycerol, and ketone body metabolism	529
719	28	12.7567299388205	28	0.0452	0.808649473684211	COPI-independent Golgi-to-ER retrograde traffic	329
1359	178	43.8566112731341	178	0.0452	0.808649473684211	Peptide ligand-binding receptors	1166
1282	455	73.3639904616426	455	0.0453	0.808649473684211	Neutrophil degranulation	1051
119	61	23.8153835334772	61	0.0456	0.808649473684211	Arachidonic acid metabolism (KEGG)	125
1548	129	33.7665874907095	135	0.0457	0.808649473684211	Role of LAT2/NTAL/LAB on calcium mobilization*	1454
358	85	28.9669097554078	85	0.0467	0.817736458333333	Rheumatoid arthritis	1401
817	36	14.6750926292857	36	0.0498	0.838999107142857	DNA Damage Recognition in GG-NER	419
787	64	21.387992631696	64	0.0507	0.838999107142857	Constitutive Signaling by Aberrant PI3K in Cancer	318
1183	99	30.4471729151729	99	0.0508	0.838999107142857	MHC class II antigen presentation	957
410	54	22.3640550169364	54	0.0513	0.838999107142857	Viral myocarditis	1846
122	68	22.3101456260066	68	0.0517	0.838999107142857	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	134
698	41	16.5717502663954	41	0.0525	0.838999107142857	Binding and Uptake of Ligands by Scavenger Receptors	186
338	155	35.3332413872826	155	0.0527	0.838999107142857	Protein processing in endoplasmic reticulum	1272
1697	43	16.0991512098458	43	0.0541	0.838999107142857	TBC/RABGAPs	1676
313	54	18.4381025089992	54	0.0544	0.838999107142857	Pathogenic Escherichia coli infection	1148
507	55	18.2875121752433	55	0.0544	0.838999107142857	Neurotrophic factor-mediated Trk receptor signaling	1049
1089	10	6.96320467311504	10	0.0544	0.838999107142857	Import of palmitoyl-CoA into the mitochondrial matrix	780
1201	79	23.3052571007133	79	0.0545	0.838999107142857	Metabolism of polyamines	943
133	32	13.5477623335455	32	0.0547	0.838999107142857	Base excision repair	169
559	15	8.87292533294982	15	0.0554	0.838999107142857	Syndecan-3-mediated signaling events	1640
1001	16	9.3563902871174	16	0.0559	0.838999107142857	GRB2 events in ERBB2 signaling	686
1655	451	69.1829989522402	451	0.0559	0.838999107142857	Signalling by NGF	1577
797	10	7.14807055528749	10	0.058	0.8405	Creatine metabolism	334
562	46	16.5475658522624	46	0.0583	0.8405	TCR signaling in naive CD8+ T cells	1681
219	18	10.6059223560751	18	0.0593	0.8405	Glycosaminoglycan degradation	667
1132	40	14.9380022655675	40	0.0605	0.8405	Intraflagellar transport	837
1330	17	9.11965428441355	17	0.0611	0.8405	PI-3K cascade:FGFR3	1195
1189	581	81.5295790281699	581	0.0612	0.8405	Membrane Trafficking	926
937	12	7.80328011234511	12	0.0622	0.8405	FGFR2c ligand binding and activation	552
1641	396	67.7134488801472	396	0.0632	0.8405	Signaling by Rho GTPases	1554
184	41	17.4003013541282	41	0.0634	0.8405	Ether lipid metabolism	510
1805	12	7.45768765408933	12	0.0635	0.8405	Unwinding of DNA	1820
943	23	11.1099212797947	23	0.0643	0.8405	FRS-mediated FGFR1 signaling	581
1378	263	47.9753862388846	263	0.0643	0.8405	Platelet activation, signaling and aggregation	1214
263	118	27.3051876163742	118	0.0646	0.8405	Lysosome	899
323	138	31.1978584000402	138	0.0647	0.8405	Phospholipase D signaling pathway	1184
950	46	16.7938296761883	46	0.0649	0.8405	Fatty Acyl-CoA Biosynthesis	531
1558	21	10.5227308042403	21	0.065	0.8405	SHC-mediated cascade:FGFR1	1492
972	83	22.4344277197247	83	0.0663	0.8405	G alpha (12/13) signalling events	587
436	77	22.3264058932021	77	0.0666	0.8405	C-MYB transcription factor network	201
946	21	10.4786311792304	21	0.0673	0.8405	FRS-mediated FGFR4 signaling	584
1055	18	9.34751740613869	18	0.0677	0.8405	HS-GAG degradation	746
1425	56	17.5370624393622	56	0.0677	0.8405	RAB geranylgeranylation	1299
432	37	13.8918237040036	37	0.068	0.8405	Aurora B signaling	153
1561	19	9.89144070367604	19	0.0692	0.8405	SHC-mediated cascade:FGFR4	1495
1063	49	16.2040048672756	49	0.0694	0.8405	Heparan sulfate/heparin (HS-GAG) metabolism	712
1563	22	10.2987696903266	22	0.0714	0.8405	SHC1 events in ERBB2 signaling	1497
424	30	12.1576208748093	30	0.0716	0.8405	Alpha-synuclein signaling	82
1424	82	21.8914691964583	82	0.0716	0.8405	RAB GEFs exchange GTP for GDP on RABs	1298
1206	116	27.6928812433755	116	0.0723	0.8405	Metabolism of water-soluble vitamins and cofactors	948
721	66	19.16252058391	66	0.0728	0.8405	COPII (Coat Protein 2) Mediated Vesicle Transport	331
1564	14	7.87277115649331	14	0.0728	0.8405	SHC1 events in ERBB4 signaling	1498
435	33	12.5915020620521	33	0.073	0.8405	BMP receptor signaling	194
883	24	10.3392048033607	24	0.0733	0.8405	Downstream signaling of activated FGFR3	441
1395	29	12.1024574304768	29	0.0735	0.8405	Pre-NOTCH Transcription and Translation	1243
932	11	7.16043692811154	11	0.0736	0.8405	FGFR1c ligand binding and activation*	547
939	11	6.80895685823213	11	0.074	0.8405	FGFR3 mutant receptor activation*	554
391	72	20.3091530974185	72	0.0741	0.8405	Thyroid hormone synthesis	1708
618	37	13.153112217972	37	0.0757	0.8405	Activation of ATR in response to replication stress	23
903	20	9.38837838110417	20	0.0757	0.8405	ERK/MAPK targets	505
551	21	9.71170439256421	21	0.0761	0.8405	Signaling events mediated by the Hedgehog family	1572
743	192	39.2130970829133	192	0.0766	0.8405	Cell Cycle Checkpoints	244
896	41	14.3636492457819	41	0.0766	0.8405	EPHB-mediated forward signaling	486
757	46	20.1060870747583	46	0.077	0.8405	Chemokine receptors bind chemokines	266
1393	46	15.3986214845424	46	0.0787	0.852579041916168	Pre-NOTCH Expression and Processing	1241
1483	13	7.09643734310549	13	0.0793	0.852579041916168	Reduction of cytosolic Ca++ levels	1317
92	16	7.9397271987838	16	0.0816	0.852579041916168	2-Oxocarboxylic acid metabolism	2
1062	596	80.0088487998665	596	0.0823	0.852579041916168	Hemostasis	709
474	55	16.0326118599447	55	0.0829	0.852579041916168	Fc-epsilon receptor I signaling in mast cells	536
901	15	8.03066809885266	15	0.0829	0.852579041916168	ERBB2 Regulates Cell Motility	501
1173	29	11.1855891681627	29	0.0829	0.852579041916168	MAPK targets/ Nuclear events mediated by MAP kinases	912
235	150	30.7294937719105	150	0.0839	0.852579041916168	Hippo signaling pathway	728
321	15	7.99855987669303	15	0.0839	0.852579041916168	Phenylalanine metabolism	1178
521	14	7.39188735349145	14	0.084	0.852579041916168	RXR and RAR heterodimerization with other nuclear receptor	1461
401	32	13.3082752273523	32	0.0842	0.852579041916168	Tyrosine metabolism	1810
1828	24	13.387072520384	24	0.0842	0.852579041916168	Xenobiotics	1864
180	64	18.1033070994057	64	0.0847	0.852579041916168	Epithelial cell signaling in Helicobacter pylori infection	490
1172	276	45.6896712030276	276	0.0861	0.853360109289618	MAPK family signaling cascades	910
368	80	20.5637403694379	80	0.0862	0.853360109289618	Small cell lung cancer	1588
351	199	35.6178440681317	199	0.0877	0.853360109289618	Regulation of actin cytoskeleton	1322
900	13	7.17925937183098	13	0.0884	0.853360109289618	ERBB2 Activates PTK6 Signaling	500
377	63	17.4197421441448	63	0.0886	0.853360109289618	Synaptic vesicle cycle	1636
137	19	9.44074324667167	19	0.0888	0.853360109289618	Biosynthesis of unsaturated fatty acids	190
905	14	7.05243270463942	14	0.0893	0.853360109289618	Early Phase of HIV Life Cycle	455
242	61	20.0565107024443	61	0.0898	0.853360109289618	Inflammatory bowel disease (IBD)	786
1539	123	26.8066699238864	123	0.0912	0.853360109289618	Response to elevated platelet cytosolic Ca2+*	1389
62	12	6.51180052188971	12	0.0914	0.853360109289618	valine degradation	1828
399	41	16.8724911889475	41	0.0916	0.853360109289618	Type I diabetes mellitus	1807
678	66	18.2702114306971	66	0.0922	0.853360109289618	Assembly of the pre-replicative complex	139
944	24	10.0446709481787	24	0.0922	0.853360109289618	FRS-mediated FGFR2 signaling	582
1741	28	10.6972477564889	28	0.0924	0.853360109289618	The role of Nef in HIV-1 replication and disease pathogenesis	1700
1689	15	7.25275489430985	15	0.0927	0.853360109289618	Synthesis of glycosylphosphatidylinositol (GPI)	1651
276	47	16.6419292139785	47	0.0929	0.853360109289618	Mineral absorption	960
1559	22	9.4574804726243	22	0.0937	0.85603097826087	SHC-mediated cascade:FGFR2	1493
463	52	15.0636419915354	52	0.0947	0.859479032258065	Endothelins	475
166	258	50.9322420249003	258	0.0951	0.859479032258065	Cytokine-cytokine receptor interaction	352
329	32	11.8544281625915	32	0.0981	0.881850802139038	Primary immunodeficiency	1250
1739	34	11.7864255031738	34	0.0995	0.886506315789474	The phototransduction cascade*	1698
974	183	33.5354821971483	183	0.0998	0.886506315789474	G alpha (q) signalling events	589
988	161	33.1538018568759	161	0.1002	0.886506315789474	G2/M Checkpoints	603
1823	20	8.28494434496518	20	0.1022	0.891361025641026	VxPx cargo-targeting to cilium	1857
1060	63	17.2950422502942	63	0.1024	0.891361025641026	Hedgehog ligand biogenesis	704
540	14	6.8916450826803	14	0.1032	0.891361025641026	S1P4 pathway	1466
558	30	10.3542757693836	30	0.1033	0.891361025641026	Syndecan-2-mediated signaling events	1639
1518	122	24.9114781022247	122	0.1034	0.891361025641026	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)*	1346
417	154	28.3457563948907	154	0.105	0.892419493670886	cGMP-PKG signaling pathway	262
1288	63	20.5899968084099	63	0.1054	0.892419493670886	Nonhomologous End-Joining (NHEJ)	1071
702	21	8.41914000526614	21	0.1068	0.892419493670886	Branched-chain amino acid catabolism	195
1012	420	56.5239755261618	420	0.108	0.892419493670886	Gastrin-CREB signalling pathway via PKC and MAPK	624
1423	21	8.76519273398074	21	0.1095	0.892419493670886	RA biosynthesis pathway	1297
1787	100	22.1438707505014	100	0.1095	0.892419493670886	Transport of inorganic cations/anions and amino acids/oligopeptides	1777
1701	32	10.9393334229935	32	0.1106	0.892419493670886	TGF-beta receptor signaling activates SMADs	1690
104	170	39.6005864914667	170	0.111	0.892419493670886	Alcoholism	73
877	26	9.65731523085556	26	0.114	0.892419493670886	Downregulation of TGF-beta receptor signaling	435
1251	370	50.1378722970548	370	0.1148	0.892419493670886	NGF signalling via TRKA from the plasma membrane	1055
938	12	6.06461929888646	12	0.1151	0.892419493670886	FGFR3 ligand binding and activation*	553
1678	27	9.56363201311998	27	0.1158	0.892419493670886	Synthesis of PC	1656
1792	159	27.8756457321547	159	0.1163	0.892419493670886	Transport to the Golgi and subsequent modification	1787
234	171	33.9372926029058	171	0.1179	0.892419493670886	Herpes simplex infection	719
1317	15	7.75417532080825	15	0.1183	0.892419493670886	Organic cation/anion/zwitterion transport	1115
7	12	6.03135128814314	12	0.1193	0.892419493670886	D-myo-inositol (1,4,5)-trisphosphate degradation	360
729	61	15.5520382234668	61	0.1199	0.892419493670886	Ca2+ pathway	206
1328	21	8.55210380342978	21	0.1204	0.892419493670886	PI-3K cascade:FGFR1	1193
1369	12	5.95349518966275	12	0.1209	0.892419493670886	Phospholipase C-mediated cascade; FGFR3	1181
107	34	13.5165434868741	34	0.1216	0.892419493670886	Allograft rejection	78
190	43	12.4232992158479	43	0.1216	0.892419493670886	Fatty acid metabolism	528
421	24	8.64491073018386	24	0.1222	0.892419493670886	ALK1 signaling events	76
1666	32	11.1286292111211	32	0.1225	0.892419493670886	Striated Muscle Contraction	1612
712	11	5.47586143631041	11	0.1231	0.892419493670886	CDC6 association with the ORC:origin complex	236
709	31	10.2028219307076	31	0.1232	0.892419493670886	CD28 co-stimulation	230
1420	24	8.57795972415503	24	0.1244	0.892419493670886	Pyrimidine metabolism (REACTOME)	1292
1292	16	6.96948044024235	16	0.1248	0.892419493670886	Norepinephrine Neurotransmitter Release Cycle	1076
1517	78	17.9695541948914	78	0.1251	0.892419493670886	Regulation of insulin secretion	1343
304	49	13.8173190549003	49	0.1257	0.892419493670886	Ovarian steroidogenesis	1121
880	191	32.0620178941973	191	0.1258	0.892419493670886	Downstream signaling events of B Cell Receptor (BCR)	437
1595	10	5.21768015521822	10	0.1261	0.892419493670886	Signal attenuation	1502
1855	88	19.1450301775889	88	0.1265	0.892419493670886	p75 NTR receptor-mediated signalling	1137
1331	19	7.9208137028655	19	0.1267	0.892419493670886	PI-3K cascade:FGFR4	1196
1580	12	6.19856174461687	12	0.127	0.892419493670886	Scavenging of heme from plasma	1475
806	10	5.05798901489735	10	0.1283	0.892419493670886	Cytosolic iron-sulfur cluster assembly	354
931	31	10.728357657122	31	0.1283	0.892419493670886	FGFR1 mutant receptor activation	546
223	24	8.43600119549555	24	0.1284	0.892419493670886	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	673
1126	104	21.487526285498	104	0.1289	0.892419493670886	Interleukin-4 and 13 signaling	829
999	50	13.1816628652176	50	0.1296	0.892419493670886	GPVI-mediated activation cascade	683
79	61	15.8169542922851	55	0.1297	0.892419493670886	Human T-lymphotropic virus (ssRNART)	756
515	40	11.6942349596202	40	0.13	0.892419493670886	PLK1 signaling events	1224
1696	25	8.70134654495182	25	0.1306	0.892419493670886	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	1670
1333	16	6.7231682156125	16	0.1315	0.892419493670886	PI3K events in ERBB2 signaling	1198
1276	40	11.3967570880849	40	0.132	0.892419493670886	Netrin-1 signaling	1042
884	26	9.14036422181263	26	0.1321	0.892419493670886	Downstream signaling of activated FGFR4	442
766	180	29.2927892692562	180	0.1336	0.892419493670886	Cilium Assembly	284
1626	68	15.8619177468663	68	0.1339	0.892419493670886	Signaling by MET	1538
693	145	26.3414897855257	145	0.1346	0.892419493670886	Beta-catenin independent WNT signaling	177
635	17	7.02175392867758	17	0.1347	0.892419493670886	Activation of SMO	41
776	21	8.05559624476942	21	0.1347	0.892419493670886	Cobalamin (Cbl, vitamin B12) transport and metabolism	304
566	42	11.7531811107392	42	0.1362	0.892419493670886	Thromboxane A2 receptor signaling	1704
278	60	14.4834578751137	60	0.1375	0.892419493670886	Mitophagy - animal	977
987	17	6.72623542922687	17	0.1375	0.892419493670886	G1/S-Specific Transcription	602
1677	31	10.5817700229794	31	0.1387	0.892419493670886	Synthesis of PA	1655
127	28	8.83104091571562	28	0.1397	0.892419493670886	Autophagy - other	158
186	38	12.339356100563	38	0.1406	0.892419493670886	Fat digestion and absorption	522
201	85	18.0247287174865	85	0.1428	0.892419493670886	Gap junction	616
779	39	12.3573560348766	39	0.143	0.892419493670886	Collagen degradation	308
1793	68	16.0055622947861	68	0.1436	0.892419493670886	Triglyceride Biosynthesis	1793
697	43	12.1585993713066	43	0.1448	0.892419493670886	Bile acid and bile salt metabolism	182
1685	34	10.4938149207426	34	0.145	0.892419493670886	Synthesis of bile acids and bile salts	1646
1437	11	5.05502783055494	11	0.1452	0.892419493670886	RHO GTPases activate KTN1	1407
1848	21	7.59835788772377	21	0.1457	0.892419493670886	mTORC1-mediated signalling	1000
695	10	4.7425424803731	10	0.1459	0.892419493670886	Beta-oxidation of pristanoyl-CoA	180
128	166	26.8842854334495	166	0.1464	0.892419493670886	Axon guidance (KEGG)	161
893	93	19.1301490502151	93	0.1465	0.892419493670886	EPH-Ephrin signaling	481
64	13	5.86125682410035	12	0.149	0.892419493670886	Chinkungunya Virus (ssRNA)	268
381	84	17.1988696016018	84	0.1521	0.892419493670886	TGF-beta signaling pathway	1692
1389	84	17.9514597189576	84	0.1523	0.892419493670886	Post-translational modification: synthesis of GPI-anchored proteins	1233
881	31	9.41788483885581	31	0.1531	0.892419493670886	Downstream signaling of activated FGFR1	439
1405	11	4.94952010321787	11	0.1534	0.892419493670886	Processive synthesis on the C-strand of the telomere	1257
644	29	10.576501614055	29	0.1548	0.892419493670886	Acyl chain remodelling of PE	49
1579	20	7.41088815520337	20	0.155	0.892419493670886	Scavenging by Class A Receptors	1474
1205	164	26.6715271413943	164	0.1555	0.892419493670886	Metabolism of vitamins and cofactors	947
135	70	15.1937196677523	70	0.1559	0.892419493670886	Bile secretion	185
1379	30	9.49108224309488	30	0.1559	0.892419493670886	Platelet calcium homeostasis	1217
748	120	22.2339377327875	120	0.1569	0.892419493670886	Cell-Cell communication	249
1180	11	4.84240400363326	11	0.1577	0.892419493670886	MET activates RAS signaling	929
102	34	9.60044346410107	34	0.1585	0.892419493670886	African trypanosomiasis	69
930	15	6.24140637724836	15	0.1594	0.892419493670886	FGFR1 ligand binding and activation	545
518	25	7.74959388152382	25	0.1602	0.892419493670886	Plasma membrane estrogen receptor signaling	1212
1615	21	7.11990194172689	21	0.1612	0.892419493670886	Signaling by FGFR3 in disease*	1526
236	28	8.36396557511649	28	0.1617	0.892419493670886	Hippo signaling pathway -multiple species	729
87	19	7.2985264814332	17	0.1618	0.892419493670886	SARS Coronavirus (ssRNA)	1473
811	349	44.3118334955684	361	0.162	0.892419493670886	DAP12 interactions*	363
725	12	5.29759599411011	12	0.1624	0.892419493670886	CS/DS degradation	340
1601	348	42.8444514239311	348	0.1625	0.892419493670886	Signaling by EGFR	1512
882	29	8.70640399076089	29	0.1627	0.892419493670886	Downstream signaling of activated FGFR2	440
1637	360	44.1595169601668	360	0.1636	0.892419493670886	Signaling by PDGF	1550
1707	96	19.175121544492	96	0.164	0.892419493670886	TNFR2 non-canonical NF-kB pathway	1719
101	139	23.2858360034049	139	0.1644	0.892419493670886	Adrenergic signaling in cardiomyocytes	66
750	14	5.46429505040341	14	0.1645	0.892419493670886	Cell-extracellular matrix interactions	251
1557	13	5.29134381692942	13	0.1646	0.892419493670886	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	1482
196	13	5.47159716147115	13	0.1647	0.892419493670886	Folate biosynthesis	560
1266	28	8.32838382441253	28	0.1661	0.892419493670886	Negative regulation of FGFR3 signaling	1031
461	32	8.94759228656704	32	0.1663	0.892419493670886	EPHB forward signaling	485
911	27	8.30101356080861	27	0.1663	0.892419493670886	Endogenous sterols	471
941	13	5.61011627668408	13	0.167	0.892419493670886	FGFR4 ligand binding and activation	556
248	82	16.1799156444842	82	0.1681	0.892419493670886	Insulin secretion	809
155	69	14.4637877734772	69	0.1682	0.892419493670886	Chronic myeloid leukemia	282
1329	22	7.48685347181375	22	0.1689	0.892419493670886	PI-3K cascade:FGFR2	1194
1830	24	7.43888276735647	24	0.1709	0.892419493670886	ZBP1(DAI) mediated induction of type I IFNs	1866
1019	42	10.5464490543182	42	0.1711	0.892419493670886	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	634
796	65	15.3844591228788	65	0.1717	0.892419493670886	Costimulation by the CD28 family	333
1490	74	15.2082395900819	74	0.174	0.892419493670886	Regulation of DNA replication*	1333
453	128	20.1334491766719	128	0.1745	0.892419493670886	Direct p53 effectors	406
715	57	13.259440266897	57	0.1746	0.892419493670886	CDT1 association with the CDC6:ORC:origin complex	240
419	147	22.8516671314794	147	0.1755	0.892419493670886	mTOR signaling pathway (KEGG)	997
35	29	8.5404306803539	29	0.1756	0.892419493670886	phospholipases	1185
354	62	13.2350209577757	62	0.1756	0.892419493670886	Renin secretion	1377
1834	13	5.44853207039996	13	0.1766	0.892419493670886	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism*	79
1604	50	11.5734989115131	50	0.1772	0.892419493670886	Signaling by ERBB2	1515
397	35	9.11957505119124	35	0.1782	0.892419493670886	Tryptophan metabolism	1805
917	13	5.18942590800768	13	0.1784	0.892419493670886	Erythrocytes take up carbon dioxide and release oxygen*	507
388	14	5.36071507801797	14	0.1786	0.892419493670886	Thiamine metabolism	1702
405	47	11.0455924865455	47	0.179	0.892419493670886	Valine, leucine and isoleucine degradation	1829
328	17	5.86854824576916	17	0.1797	0.892419493670886	Primary bile acid biosynthesis	1249
125	49	14.9050996594866	49	0.1803	0.892419493670886	Autoimmune thyroid disease	156
1485	10	4.30166600989343	10	0.1803	0.892419493670886	Regulated proteolysis of p75NTR	1320
1692	19	6.18991752997775	19	0.1813	0.892419493670886	Synthesis, secretion, and deacylation of Ghrelin	1664
1360	28	7.80456906847504	28	0.1815	0.892419493670886	Peroxisomal lipid metabolism	1168
353	59	12.4083467645923	59	0.1819	0.892419493670886	Renal cell carcinoma	1376
1674	10	4.26597166584657	10	0.1822	0.892419493670886	Synthesis of IP2, IP, and Ins in the cytosol	1652
97	11	5.04492495801651	11	0.1842	0.892419493670886	Acylglycerol degradation	53
1609	38	10.0486355344611	38	0.1852	0.892419493670886	Signaling by FGFR1 in disease	1520
1756	142	22.297172577119	142	0.1853	0.892419493670886	Toll-Like Receptors Cascades	1731
20	13	4.93199975705203	13	0.1859	0.892419493670886	fatty acid beta-oxidation (peroxisome)	524
1210	15	5.45337336147104	15	0.186	0.892419493670886	Methylation	955
1020	30	8.20676309086471	30	0.1884	0.892419493670886	Glucagon-type ligand receptors	635
117	132	20.9475961447323	132	0.1885	0.892419493670886	Apoptosis (KEGG)	118
603	12	4.7706616859876	12	0.1901	0.892419493670886	ATF6 (ATF6-alpha) activates chaperones	147
420	65	12.7012656241866	65	0.1913	0.892419493670886	p53 signaling pathway	1132
394	107	19.6055334867411	107	0.1921	0.892419493670886	Toxoplasmosis	1732
1138	53	11.4747261983851	53	0.1933	0.892419493670886	Ion transport by P-type ATPases	843
31	12	4.52767495084273	12	0.194	0.892419493670886	leucine degradation	875
150	99	17.0258725690506	99	0.194	0.892419493670886	Chagas disease (American trypanosomiasis)	263
1209	11	6.50643058437436	11	0.194	0.892419493670886	Metallothioneins bind metals*	952
333	32	8.26138058959072	32	0.1951	0.892419493670886	Propanoate metabolism	1264
61	10	4.47942307577	10	0.1954	0.892419493670886	triacylglycerol degradation	1790
124	27	9.28577802083263	27	0.1956	0.892419493670886	Asthma	142
825	31	7.97539106582216	31	0.1958	0.892419493670886	DNA strand elongation	428
1654	221	29.4418896784946	221	0.1963	0.892419493670886	Signaling by the B Cell Receptor (BCR)	1558
926	29	7.68143450277802	29	0.1966	0.892419493670886	FCERI mediated Ca+2 mobilization	537
191	66	13.5534308970894	66	0.1967	0.892419493670886	Fc epsilon RI signaling pathway	534
647	22	7.34848049990626	22	0.197	0.892419493670886	Acyl chain remodelling of PS	52
314	381	42.4202158681094	381	0.1972	0.892419493670886	Pathways in cancer	1149
387	102	18.7219159463485	102	0.1978	0.892419493670886	Th17 cell differentiation	1694
297	25	7.16705285355346	25	0.1982	0.892419493670886	O-glycan biosynthesis, mucin type core	1099
1818	93	16.4207454489695	93	0.1984	0.892419493670886	Visual phototransduction	1847
200	29	7.84007490711714	29	0.1999	0.892419493670886	Galactose metabolism	612
689	37	8.77181162598001	37	0.2	0.892419493670886	Base Excision Repair*	170
1310	32	8.06923891241883	32	0.2003	0.892419493670886	Oncogene Induced Senescence	1106
77	317	38.5994355360305	298	0.2004	0.892419493670886	Human Immunodeficiency Virus type 1 (ssRNART)	753
1296	23	6.57962070298932	23	0.2005	0.892419493670886	Nuclear Events (kinase and transcription factor activation)	1089
1372	20	7.45349861451657	20	0.2006	0.892419493670886	Phosphorylation of CD3 and TCR zeta chains	1187
93	42	10.2744311036174	42	0.2012	0.892419493670886	ABC transporters	9
1441	20	6.04188429941588	20	0.2025	0.892419493670886	RIP-mediated NFkB activation via ZBP1	1419
643	27	8.18535489711675	27	0.2029	0.892419493670886	Acyl chain remodelling of PC	48
1708	27	8.09002631159996	27	0.2033	0.892419493670886	TNFs bind their physiological receptors	1720
822	104	17.2505658480743	104	0.2035	0.892419493670886	DNA Replication	426
871	72	14.2878270512443	72	0.2035	0.892419493670886	Disorders of transmembrane transporters	416
84	14	5.6123974054073	11	0.2046	0.892419493670886	Murine Gammaherpesvirus (dsDNA)	1003
1281	46	10.2933551090777	46	0.2046	0.892419493670886	Neurotransmitter Release Cycle	1048
441	73	13.6664102730912	73	0.2049	0.892419493670886	CXCR4-mediated signaling events	343
514	54	11.1346661956311	54	0.2051	0.892419493670886	PDGFR-beta signaling pathway	1158
1274	19	5.76464910858904	19	0.2052	0.892419493670886	Nephrin interactions	1039
788	16	5.2306387425774	16	0.2053	0.892419493670886	Constitutive Signaling by EGFRvIII*	320
218	10	4.17883662516926	10	0.2066	0.892419493670886	Glycosaminoglycan biosynthesis, heparan sulfate backbone	666
1522	49	10.9043907484972	49	0.2074	0.892419493670886	Regulation of ornithine decarboxylase (ODC)	1352
484	27	7.19248999036472	27	0.2078	0.892419493670886	IGF1 pathway	763
1192	15	5.3265630355231	15	0.2082	0.892419493670886	Metabolism of Angiotensinogen to Angiotensins	935
1688	24	6.96552126972078	24	0.2083	0.892419493670886	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	1649
306	148	22.1943757245041	148	0.2104	0.892419493670886	Oxytocin signaling pathway	1126
1119	68	14.9646419340683	68	0.2108	0.892419493670886	Interferon alpha/beta signaling	821
815	13	4.53643471529059	13	0.2111	0.892419493670886	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	402
1324	21	7.58820995678858	21	0.2114	0.892419493670886	PD-1 signaling	1156
465	13	4.70504551905369	13	0.2118	0.892419493670886	ErbB receptor signaling network	497
450	39	8.76918820567971	39	0.2119	0.892419493670886	Class I PI3K signaling events	297
1335	88	14.9828416543609	88	0.2121	0.892419493670886	PI3K/AKT Signaling in Cancer	1202
598	70	13.402225819901	70	0.2122	0.892419493670886	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	115
30	11	3.96621365497278	11	0.2128	0.892419493670886	isoleucine degradation	853
490	51	10.3954624804	51	0.2128	0.892419493670886	IL2-mediated signaling events	773
1367	16	5.38594470867898	16	0.2128	0.892419493670886	Phospholipase C-mediated cascade: FGFR1	1183
1778	17	6.72768986748793	17	0.2128	0.892419493670886	Translocation of ZAP-70 to Immunological synapse	1773
1788	11	4.3964665031056	11	0.2129	0.892419493670886	Transport of organic anions	1782
1769	29	7.25051707907225	29	0.2135	0.892419493670886	Transferrin endocytosis and recycling	1764
628	31	8.50258881263203	31	0.2136	0.892419493670886	Activation of Matrix Metalloproteinases	34
1524	18	5.27124729697858	18	0.2137	0.892419493670886	Regulation of signaling by CBL	1360
918	11	5.12489974603852	11	0.2138	0.892419493670886	Ethanol oxidation	509
1429	257	31.1260680158414	257	0.2138	0.892419493670886	RET signaling	1391
142	172	23.7183904407471	172	0.2139	0.892419493670886	Calcium signaling pathway	210
209	50	10.6780784865454	50	0.2139	0.892419493670886	Glycerolipid metabolism	651
1427	22	5.98892869511796	22	0.2145	0.892419493670886	RAF-independent MAPK1/3 activation	1302
408	49	10.0185529149371	49	0.2163	0.892419493670886	Vibrio cholerae infection	1841
1513	53	10.3637495304568	53	0.2164	0.892419493670886	Regulation of cholesterol biosynthesis by SREBP (SREBF)	1330
1781	79	13.6608647418232	79	0.217	0.892419493670886	Transport of Mature Transcript to Cytoplasm	1781
1319	34	7.91510920236923	34	0.2173	0.892419493670886	Ovarian tumor domain proteases	1122
1264	32	7.76083334342877	32	0.2185	0.892419493670886	Negative regulation of FGFR1 signaling	1029
616	16	5.17615604563233	16	0.2195	0.892419493670886	Activated point mutants of FGFR2	18
641	11	3.90598073891559	11	0.2195	0.892419493670886	Activation of the phototransduction cascade	44
384	11	3.93494104002651	11	0.2202	0.892419493670886	Taurine and hypotaurine metabolism	1675
1566	11	3.97385965919644	11	0.2203	0.892419493670886	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	1584
542	30	7.22462135809809	30	0.2216	0.892419493670886	Signaling events mediated by HDAC Class II	1565
1706	13	4.16936426608921	13	0.2218	0.892419493670886	TNFR1-induced proapoptotic signaling	1718
1351	50	14.0276289539461	50	0.2219	0.892419493670886	Packaging Of Telomere Ends	1141
813	26	6.63698179350903	26	0.2221	0.892419493670886	DARPP-32 events	365
1112	66	12.5006279831405	66	0.2222	0.892419493670886	Integrin cell surface interactions	814
1481	16	5.02516593273386	16	0.223	0.892419493670886	Recycling of bile acids and salts	1315
1542	14	4.49093877319044	14	0.2237	0.892419493670886	Retrograde neurotrophin signalling	1397
1370	14	4.7546546081147	14	0.2241	0.892419493670886	Phospholipase C-mediated cascade; FGFR4	1182
282	15	4.57402256880019	15	0.2245	0.892419493670886	N-glycan biosynthesis, complex type	1016
109	47	9.51472916996046	47	0.2263	0.892419493670886	Amino sugar and nucleotide sugar metabolism	90
361	32	7.47067080640704	32	0.2272	0.892419493670886	SNARE interactions in vesicular transport	1590
746	79	13.5924262850571	79	0.2273	0.892419493670886	Cell junction organization	247
1744	10	3.67023875910384	10	0.228	0.892419493670886	Thyroxine biosynthesis	1709
289	28	6.91490036223531	28	0.2288	0.892419493670886	Nicotinate and nicotinamide metabolism	1057
1398	12	4.45799570039687	12	0.2288	0.892419493670886	Presynaptic nicotinic acetylcholine receptors	1247
690	10	3.58577651807568	10	0.2294	0.892419493670886	Base-Excision Repair, AP Site Formation	171
1768	83	13.6587048813046	83	0.2298	0.892419493670886	Transcriptional regulation of white adipocyte differentiation	1763
774	128	17.898237958678	128	0.2299	0.892419493670886	Clathrin-mediated endocytosis	300
422	11	3.77277908184341	11	0.23	0.892419493670886	ALK2 signaling events	77
1243	15	4.47089289071317	15	0.23	0.892419493670886	N-Glycan antennae elongation	1013
467	35	7.63876723761276	35	0.2302	0.892419493670886	ErbB2/ErbB3 signaling events	502
308	70	12.3679535456732	70	0.2311	0.892419493670886	PPAR signaling pathway	1238
1836	18	5.18023480694923	18	0.2311	0.892419493670886	cGMP effects	261
1529	12	4.11517597993942	12	0.2315	0.892419493670886	Repression of WNT target genes	1379
1267	30	7.12954324286448	30	0.2322	0.892419493670886	Negative regulation of FGFR4 signaling	1032
1400	10	3.56324833383588	10	0.2326	0.892419493670886	Processing and activation of SUMO	1252
1722	24	6.12354462353372	24	0.2329	0.892419493670886	TRAF6 mediated NF-kB activation	1748
833	16	4.79872968571463	16	0.2336	0.892419493670886	Defective B3GALT6 causes EDSP2 and SEMDJL1*	373
648	763	68.9690645888962	763	0.2339	0.892419493670886	Adaptive Immune System	54
1648	324	38.8153489623041	324	0.234	0.892419493670886	Signaling by Wnt	1561
934	19	5.62018327738495	19	0.2343	0.892419493670886	FGFR2 ligand binding and activation	549
585	66	12.4141931619895	66	0.2348	0.892419493670886	ABC transporter disorders	8
1705	22	5.72788793361999	22	0.235	0.892419493670886	TNFR1-induced NFkappaB signaling pathway	1717
46	19	5.26041640691967	19	0.2352	0.892419493670886	superpathway of D-myo-inositol (1,4,5)-trisphosphate metabolism	1623
45	11	4.10933022264553	11	0.2355	0.892419493670886	stearate biosynthesis	1607
1750	118	16.6848640581369	118	0.2361	0.892419493670886	Toll Like Receptor 4 (TLR4) Cascade	1724
1137	53	10.2062316087279	53	0.2371	0.892419493670886	Ion homeostasis	842
1166	34	7.4067789758972	34	0.2373	0.892419493670886	Lysosome Vesicle Biogenesis	900
1789	34	7.4285604564903	34	0.2378	0.892419493670886	Transport of the SLBP Dependant Mature mRNA*	1784
1039	108	15.522748815117	108	0.2381	0.892419493670886	Golgi-to-ER retrograde transport	680
307	330	35.6780329771416	330	0.2399	0.892419493670886	PI3K-Akt signaling pathway	1200
819	71	13.8769365276474	71	0.2399	0.892419493670886	DNA Double Strand Break Response*	421
188	42	9.29734554370811	42	0.2401	0.892419493670886	Fatty acid degradation	526
415	12	3.98326621216656	12	0.2401	0.892419493670886	beta-Oxidation	179
1029	119	17.3397966635438	119	0.2401	0.892419493670886	Glycerophospholipid biosynthesis	652
1314	320	33.4570793608455	320	0.2408	0.892419493670886	Organelle biogenesis and maintenance	1112
1065	56	10.9244590567492	56	0.2412	0.892419493670886	Hh mutants abrogate ligand secretion*	722
602	11	3.80876771484014	11	0.2414	0.892419493670886	ATF6 (ATF6-alpha) activates chaperone genes	146
1244	26	6.08492011008435	26	0.2427	0.892419493670886	N-glycan antennae elongation in the medial/trans-Golgi	1014
656	17	4.6696372872379	17	0.2431	0.892419493670886	Amine-derived hormones	87
1106	44	8.62918404225354	44	0.2444	0.892419493670886	Inositol phosphate metabolism (REACTOME)	802
1673	97	14.8252208854897	97	0.246	0.892419493670886	Synthesis of DNA	1650
264	244	28.0355434545528	244	0.2465	0.892419493670886	MAPK signaling pathway	911
637	41	7.82630949551631	41	0.2467	0.892419493670886	Activation of gene expression by SREBF (SREBP)	30
197	127	16.7852283877031	127	0.2471	0.892419493670886	FoxO signaling pathway	580
1757	12	3.89664080734157	12	0.2471	0.892419493670886	Trafficking and processing of endosomal TLR	1749
1638	67	11.2130277406678	67	0.2472	0.892419493670886	Signaling by PTK6	1551
1620	132	18.2084059109048	132	0.2482	0.892419493670886	Signaling by Hedgehog	1531
126	119	15.8918922133259	119	0.2488	0.892419493670886	Autophagy - animal	157
1272	93	13.8391383004735	93	0.2491	0.892419493670886	Negative regulation of the PI3K/AKT network	1036
454	48	9.04991482123067	48	0.2495	0.892419493670886	Downstream signaling in naive CD8+ T cells	438
823	81	12.8902009905129	81	0.251	0.892419493670886	DNA Replication Pre-Initiation*	427
1643	323	33.2714973159834	323	0.2514	0.892419493670886	Signaling by SCF-KIT	1556
621	11	3.42697486198288	11	0.2515	0.892419493670886	Activation of Ca-permeable Kainate Receptor*	26
1054	28	6.41964211837398	28	0.2516	0.892419493670886	HS-GAG biosynthesis	745
433	28	6.2036379984272	28	0.2519	0.892419493670886	BARD1 signaling events	166
1403	93	15.1913705811375	93	0.2521	0.892419493670886	Processing of DNA double-strand break ends	1255
29	18	4.93225670591412	18	0.2534	0.892419493670886	heparan sulfate biosynthesis (late stages)	711
99	66	10.632207912223	66	0.2534	0.892419493670886	Adherens junction	60
1236	194	23.8594619112827	194	0.2551	0.892419493670886	Muscle contraction	1005
14	11	3.4597216861925	11	0.2552	0.892419493670886	cholesterol biosynthesis I*	271
1108	26	5.95749518511182	26	0.2552	0.892419493670886	Insulin receptor recycling	806
1014	135	21.7799513130928	135	0.2559	0.892419493670886	Gene Silencing by RNA	626
170	126	16.7004423186713	126	0.2565	0.892419493670886	Dopaminergic synapse	430
90	51	9.57653673735121	47	0.2569	0.892419493670886	Vaccinia Virus (dsDNA)	1824
522	10	3.22003687938917	10	0.258	0.892419493670886	Ras signaling in the CD4+ TCR pathway	1307
710	21	5.1384025849178	21	0.2581	0.892419493670886	CD28 dependent PI3K/Akt signaling	231
350	217	24.8739153342142	217	0.2583	0.892419493670886	Ras signaling pathway	1308
1528	10	3.23247037408184	10	0.2592	0.892419493670886	Removal of the Flap Intermediate from the C-strand	1375
1711	48	8.37489768311124	48	0.2592	0.892419493670886	TP53 Regulates Transcription of Cell Cycle Genes	1736
442	44	8.25039351214088	44	0.2597	0.892419493670886	Calcineurin-regulated NFAT-dependent transcription in lymphocytes	207
936	10	3.38874879009388	10	0.2599	0.892419493670886	FGFR2b ligand binding and activation	551
610	14	4.24581604360717	14	0.2603	0.892419493670886	Acetylcholine Binding And Downstream Events*	13
1233	21	5.002579787629	21	0.2611	0.892419493670886	Mitotic Spindle Checkpoint*	984
1285	22	5.31903509096188	22	0.2611	0.892419493670886	Nitric oxide stimulates guanylate cyclase	1061
1488	51	9.52242544371026	51	0.2614	0.892419493670886	Regulation of Apoptosis	1327
254	13	3.69736514395205	13	0.2615	0.892419493670886	Leucine degradation, leucine => acetoacetate + acetyl-CoA	876
1596	12	3.79109755706355	12	0.2617	0.892419493670886	Signal regulatory protein (SIRP) family interactions	1503
639	12	3.78092754855557	12	0.2625	0.892419493670886	Activation of the TFAP2 (AP-2) family of transcription factors	46
1188	76	14.3448496055161	76	0.2631	0.892419493670886	Meiotic synapsis	921
280	29	6.30434539894418	29	0.2632	0.892419493670886	Mucin type O-glycan biosynthesis	1002
1130	172	20.1353029370095	172	0.2633	0.892419493670886	Intra-Golgi and retrograde Golgi-to-ER traffic	835
1608	49	8.8490156652356	49	0.2633	0.892419493670886	Signaling by FGFR1	1519
1193	329	32.2016421488176	329	0.2636	0.892419493670886	Metabolism of amino acids and derivatives	934
821	299	31.1933267492892	299	0.2641	0.892419493670886	DNA Repair	424
1702	16	4.33480905694579	16	0.2643	0.892419493670886	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1691
1047	10	3.22137203474917	10	0.2649	0.892419493670886	HDR through MMEJ (alt-NHEJ)	700
1783	68	10.5927769215783	68	0.2651	0.892419493670886	Transport of Mature mRNA derived from an Intron-Containing Transcript	1778
221	14	3.86605389633034	14	0.2654	0.892419493670886	Glycosphingolipid biosynthesis - globo and isoglobo series	670
233	127	17.3372675289788	127	0.2658	0.892419493670886	Hepatitis C	716
1613	39	7.36248234092266	39	0.2668	0.892419493670886	Signaling by FGFR3	1524
804	65	11.7175839212512	65	0.267	0.892419493670886	Cytochrome P450 - arranged by substrate type	350
594	84	12.5447407633853	84	0.2685	0.892419493670886	APC/C-mediated degradation of cell cycle proteins*	111
434	63	10.1140752256091	63	0.2687	0.892419493670886	BCR signaling pathway	174
19	13	3.62831576337853	13	0.2689	0.892419493670886	fatty acid beta-oxidation	523
1265	33	6.69558301181274	33	0.2689	0.892419493670886	Negative regulation of FGFR2 signaling	1030
954	82	11.9126436755177	82	0.2707	0.892419493670886	Fcgamma receptor (FCGR) dependent phagocytosis	540
868	79	11.8630249915851	79	0.2712	0.892419493670886	Diseases of glycosylation	412
1501	16	4.5805619328065	16	0.2719	0.892419493670886	Regulation of TLR by endogenous ligand	1363
596	65	10.582095254498	65	0.2723	0.892419493670886	APC/C:Cdc20 mediated degradation of Securin	114
629	64	10.5611676372805	64	0.2725	0.892419493670886	Activation of NF-kappaB in B cells	35
820	161	20.1184855052281	161	0.2738	0.892419493670886	DNA Double-Strand Break Repair	422
1007	10	3.05049619652887	10	0.2745	0.892419493670886	Gap junction degradation	618
775	65	10.2389060029376	65	0.2747	0.892419493670886	Cleavage of Growing Transcript in the Termination Region*	301
655	39	7.50805756743754	39	0.2748	0.892419493670886	Amine ligand-binding receptors	86
807	65	10.0082865712725	65	0.2749	0.892419493670886	Cytosolic sensors of pathogen-associated DNA	355
1306	105	13.866497063823	105	0.2751	0.892419493670886	O-linked glycosylation	1101
927	252	26.1303388134626	252	0.2761	0.892419493670886	FCERI mediated MAPK activation	538
1247	36	6.97517253728026	36	0.2766	0.892419493670886	NCAM1 interactions	1023
1305	35	6.50285472123879	35	0.2794	0.892419493670886	O-glycosylation of TSR domain-containing proteins*	1100
1368	17	4.32069437706295	17	0.2794	0.892419493670886	Phospholipase C-mediated cascade; FGFR2	1180
89	10	3.00398621596798	9	0.2799	0.892419493670886	Sindbis Virus (ssRNA)	1582
202	74	10.9426501241879	74	0.2799	0.892419493670886	Gastric acid secretion	623
1182	10	3.06261503722421	10	0.2805	0.892419493670886	MET receptor recycling	931
982	47	7.94793524052751	47	0.2823	0.892419493670886	G-protein mediated events*	597
1715	20	4.55603771381074	20	0.2824	0.892419493670886	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1740
340	20	4.62975022784856	20	0.2826	0.892419493670886	Proximal tubule bicarbonate reclamation	1277
906	26	5.41963103631668	26	0.2828	0.892419493670886	Effects of PIP2 hydrolysis	459
898	128	15.3256857760793	128	0.2833	0.892419493670886	ER to Golgi Anterograde Transport	495
925	53	9.29554364987628	53	0.2837	0.892419493670886	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	532
1811	22	4.87963746050085	22	0.2845	0.892419493670886	VLDL interactions	1852
942	13	3.59378375767548	13	0.2848	0.892419493670886	FGFRL1 modulation of FGFR1 signaling	557
1196	16	3.8569076356877	16	0.2852	0.892419493670886	Metabolism of folate and pterines	938
1131	43	7.46189250511315	43	0.2863	0.892419493670886	Intra-Golgi traffic	836
1784	43	7.42855768987628	43	0.2864	0.892419493670886	Transport of Mature mRNAs Derived from Intronless Transcripts*	1780
88	25	5.26820103898836	23	0.2872	0.892419493670886	Simian Virus 40 (dsDNA)	1581
261	51	8.24059363766397	51	0.2875	0.892419493670886	Lysine degradation	897
1332	77	11.0442292870176	77	0.2891	0.892419493670886	PI3K Cascade	1197
524	46	7.49765109912442	46	0.2892	0.892419493670886	Regulation of Androgen receptor activity	1325
232	139	17.3998136302113	139	0.2896	0.892419493670886	Hepatitis B	713
765	25	5.30338731819662	25	0.2896	0.892419493670886	Chylomicron-mediated lipid transport	283
1839	56	8.84404961424004	56	0.2898	0.892419493670886	mRNA 3'-end processing	988
1617	40	6.90797931872027	40	0.2906	0.892419493670886	Signaling by FGFR4	1528
989	90	13.3634310443651	90	0.2907	0.892419493670886	G2/M DNA damage checkpoint	604
335	44	7.85818598651008	44	0.2915	0.892419493670886	Proteasome	1267
575	22	4.64978384582231	22	0.2918	0.892419493670886	Visual signal transduction: Rods	1849
198	30	5.85559714672954	30	0.2934	0.892419493670886	Fructose and mannose metabolism	586
683	61	9.37006396711258	61	0.2957	0.892419493670886	Autodegradation of Cdh1 by Cdh1:APC/C	154
486	28	5.60246799644343	28	0.2958	0.892419493670886	IL12 signaling mediated by STAT4	769
538	23	4.93612708424026	23	0.2959	0.892419493670886	S1P2 pathway	1464
1703	16	4.01178487592021	16	0.2967	0.892419493670886	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1714
1337	86	11.3449995422986	86	0.2969	0.892419493670886	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	1203
189	21	4.72002438915506	21	0.297	0.892419493670886	Fatty acid elongation	527
1073	124	14.8762364268375	124	0.2976	0.892419493670886	Host Interactions of HIV factors	743
805	722	58.5089296148981	722	0.2977	0.892419493670886	Cytokine Signaling in Immune system	351
1686	14	3.77673220510433	14	0.298	0.892419493670886	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	1647
894	47	7.5555643183366	47	0.2985	0.892419493670886	EPH-ephrin mediated repulsion of cells	480
501	63	9.20112595745341	63	0.2986	0.892419493670886	LPA receptor mediated events	894
584	23	4.69486567739774	23	0.299	0.892419493670886	A tetrasaccharide linker sequence is required for GAG synthesis	5
1390	954	71.0880873023394	954	0.3006	0.892419493670886	Post-translational protein modification	1234
1812	12	3.13501661862052	12	0.301	0.892419493670886	VLDLR internalisation and degradation	1853
1622	307	28.6383195622952	307	0.3014	0.892419493670886	Signaling by Insulin receptor	1534
285	161	18.9290881507447	161	0.3021	0.892419493670886	NOD-like receptor signaling pathway	1063
638	10	2.72609672860326	10	0.3023	0.892419493670886	Activation of the AP-1 family of transcription factors	42
1246	262	25.6019436716469	262	0.3024	0.892419493670886	NCAM signaling for neurite out-growth	1022
1567	10	2.72590579857731	10	0.3025	0.892419493670886	SLBP independent Processing of Histone Pre-mRNAs	1585
953	355	32.178836778764	355	0.3027	0.892419493670886	Fc epsilon receptor (FCERI) signaling	533
1531	24	4.73430834979392	24	0.3053	0.892419493670886	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	1382
633	10	2.79896838581156	10	0.3056	0.892419493670886	Activation of PUMA and translocation to mitochondria	39
1334	10	2.78205524068572	10	0.3056	0.892419493670886	PI3K events in ERBB4 signaling	1199
587	101	12.8022306639663	101	0.3066	0.892419493670886	ABC-family proteins mediated transport	11
1350	27	4.98912988599571	27	0.3066	0.892419493670886	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	1278
1550	123	14.4395328365707	123	0.3066	0.892419493670886	S Phase	1462
1315	10	2.78619627502851	10	0.3069	0.892419493670886	Organic anion transporters	1113
72	161	18.0659731173445	145	0.3074	0.892419493670886	Hepatitis C Virus (ssRNA)	718
660	93	11.5007934921502	93	0.3079	0.892419493670886	Anchoring of the basal body to the plasma membrane	97
1660	13	3.09109284217876	13	0.3084	0.892419493670886	Sodium/Calcium exchangers	1592
349	204	20.0414484882128	204	0.3091	0.892419493670886	Rap1 signaling pathway	1304
112	65	9.01747472503158	65	0.3092	0.892419493670886	Amphetamine addiction	93
671	35	5.8618133149198	35	0.31	0.892419493670886	Apoptotic cleavage of cellular proteins	122
1017	82	10.4604774274662	82	0.3101	0.892419493670886	Global Genome Nucleotide Excision Repair (GG-NER)	631
389	29	5.10002663529009	29	0.3102	0.892419493670886	Thyroid cancer	1706
1510	59	8.45613028769724	59	0.3115	0.892419493670886	Regulation of actin dynamics for phagocytic cup formation	1323
416	191	18.8632547103467	191	0.3126	0.892419493670886	cAMP signaling pathway	214
672	49	7.35051001069694	49	0.313	0.892419493670886	Apoptotic execution phase	123
187	12	2.98507449694335	12	0.3131	0.892419493670886	Fatty acid biosynthesis	525
1197	758	56.1591079897619	758	0.3133	0.892419493670886	Metabolism of lipids and lipoproteins	939
1732	78	12.2449377813868	78	0.3133	0.892419493670886	Telomere Maintenance	1683
838	59	8.98673364253106	59	0.3136	0.892419493670886	Defective CFTR causes cystic fibrosis	378
1419	12	2.87202348171749	12	0.315	0.892419493670886	Pyrimidine catabolism	1287
997	932	77.209697616451	925	0.3155	0.892419493670886	GPCR downstream signaling	681
831	57	8.43204961579721	57	0.3156	0.892419493670886	Dectin-1 mediated noncanonical NF-kB signaling*	371
760	19	3.88924204444316	19	0.3158	0.892419493670886	Chondroitin sulfate biosynthesis	277
147	121	13.3027354627363	121	0.3161	0.892419493670886	Cell cycle	242
1525	11	2.72549029211876	11	0.3162	0.892419493670886	Regulation of signaling by NODAL	1361
1829	28	4.92807495347887	28	0.3168	0.892419493670886	YAP1- and WWTR1 (TAZ)-stimulated gene expression	1865
1270	15	3.40944575063462	15	0.317	0.892419493670886	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	1035
1628	108	12.7080472389529	108	0.3172	0.892419493670886	Signaling by NOTCH	1541
1222	92	11.2514272045594	92	0.3181	0.892419493670886	Mitochondrial translation	971
1223	86	11.2514272045594	92	0.3181	0.892419493670886	Mitochondrial translation elongation*	972
1745	18	3.62115289357946	18	0.3183	0.892419493670886	Tie2 Signaling	1710
1341	17	3.55337320531642	17	0.3195	0.892419493670886	PKA activation in glucagon signalling	1208
864	56	8.01044104924622	56	0.3197	0.892419493670886	Diseases associated with O-glycosylation of proteins	410
1298	48	7.3521786277188	48	0.3206	0.892419493670886	Nuclear Receptor transcription pathway	1092
579	60	8.04031016645899	60	0.3213	0.892419493670886	mTOR signaling pathway (PID)	998
1585	27	4.81711758188495	27	0.3217	0.892419493670886	Sema4D in semaphorin signaling	1483
311	18	3.79509802819473	18	0.3218	0.892419493670886	Pantothenate and CoA biosynthesis	1144
395	169	17.4951282612884	169	0.3223	0.892419493670886	Transcriptional misregulation in cancer	1758
1136	190	19.1834531029051	190	0.3235	0.892419493670886	Ion channel transport	841
888	10	2.54140145783068	10	0.3239	0.892419493670886	E2F-enabled inhibition of pre-replication complex formation	453
1718	20	3.80588521784248	20	0.3243	0.892419493670886	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	1734
785	71	12.7238447692875	71	0.3253	0.892419493670886	Condensation of Prophase Chromosomes	317
1215	14	3.02653979361262	14	0.3257	0.892419493670886	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	965
265	44	6.58198789844482	44	0.3264	0.892419493670886	Malaria	905
324	27	4.82717294957032	27	0.3276	0.892419493670886	Phototransduction	1190
1237	78	9.67392485741392	78	0.3276	0.892419493670886	MyD88 cascade initiated on plasma membrane*	1006
684	49	7.74128936999557	54	0.3287	0.892419493670886	Autodegradation of the E3 ubiquitin ligase COP1*	155
1271	10	2.51568801453834	10	0.3288	0.892419493670886	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	1028
1322	21	3.84359633871723	21	0.33	0.892419493670886	PCNA-Dependent Long Patch Base Excision Repair	1154
1592	33	5.37758156164498	33	0.3301	0.892419493670886	Sialic acid metabolism	1500
738	50	6.96811057770466	50	0.3303	0.892419493670886	Cargo trafficking to the periciliary membrane	224
85	14	3.00777310338103	14	0.3316	0.892419493670886	Murine Leukemia Virus (ssRNART)	1004
74	52	7.32556983588717	49	0.332	0.892419493670886	Human Cytomegalovirus (dsDNA)	750
1589	155	15.7258016254276	155	0.3322	0.892419493670886	Separation of Sister Chromatids	1488
1177	10	2.38366509753124	10	0.3324	0.892419493670886	MASTL Facilitates Mitotic Progression	916
617	74	9.43237401624695	74	0.333	0.892419493670886	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins*	22
1779	635	47.9236923808996	635	0.334	0.892419493670886	Transmembrane transport of small molecules	1774
1646	322	26.8264163396593	322	0.3344	0.892419493670886	Signaling by VEGF*	1560
153	93	10.8033803047345	93	0.3354	0.892419493670886	Choline metabolism in cancer	274
1015	28	5.35031656347371	28	0.3357	0.892419493670886	Generation of second messenger molecules	627
1262	21	3.88994192054617	21	0.3358	0.892419493670886	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	1026
225	90	10.3981808027059	90	0.3364	0.892419493670886	GnRH signaling pathway	677
1716	13	2.74468293611331	13	0.3375	0.892419493670886	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	1741
407	43	6.08124492643398	43	0.3377	0.892419493670886	Vasopressin-regulated water reabsorption	1833
1214	15	3.04571454170853	15	0.3385	0.892419493670886	Mismatch Repair	964
1822	50	7.38197936062309	50	0.3392	0.892419493670886	Vpu mediated degradation of CD4	1856
255	107	11.4296059161134	107	0.3394	0.892419493670886	Leukocyte transendothelial migration	877
537	20	3.60442929439941	20	0.3399	0.892419493670886	S1P1 pathway	1463
299	19	3.48042418076885	19	0.34	0.892419493670886	One carbon pool by folate	1108
863	803	56.2681948949748	803	0.3412	0.892419493670886	Disease	408
498	33	5.04863471711234	33	0.3422	0.892419493670886	Internalization of ErbB1	833
1482	22	3.8376009960324	22	0.3422	0.892419493670886	Recycling pathway of L1	1316
303	20	3.52004272099109	20	0.3436	0.892419493670886	Other types of O-glycan biosynthesis	1120
1	14	2.81326962434818	14	0.3437	0.892419493670886	1D-myo-inositol hexakisphosphate biosynthesis II (mammalian)	1
1211	25	4.42472450747035	25	0.344	0.892419493670886	MicroRNA (miRNA) biogenesis	958
967	90	12.7597710710545	90	0.3445	0.892419493670886	Formation of the beta-catenin:TCF transactivating complex	570
108	147	14.2563778343322	147	0.3456	0.892419493670886	Alzheimer's disease	83
770	88	10.1646818680248	88	0.3456	0.892419493670886	Class B/2 (Secretin family receptors)	294
106	36	5.24925819977016	36	0.3468	0.892419493670886	Aldosterone-regulated sodium reabsorption	75
663	37	5.26946320071877	37	0.3473	0.892419493670886	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	101
1184	62	7.50273100594682	62	0.348	0.892419493670886	Macroautophagy	903
1430	278	25.1480908135673	278	0.3482	0.892419493670886	RHO GTPase Effectors	1403
471	41	5.73704619108213	41	0.3486	0.892419493670886	FOXA1 transcription factor network	576
1584	14	2.78790886130669	14	0.3497	0.892419493670886	Sema3A PAK dependent Axon repulsion	1481
1621	19	3.37416553917277	19	0.35	0.892419493670886	Signaling by Hippo	1533
1623	500	38.0392306149673	500	0.35	0.892419493670886	Signaling by Interleukins	1535
1651	18	3.42687367842403	18	0.3501	0.892419493670886	Signaling by cytosolic FGFR1 fusion mutants	1511
1241	87	9.728905080693	87	0.3516	0.892419493670886	MyD88:Mal cascade initiated on plasma membrane*	1010
1687	15	3.01243790677021	15	0.3521	0.892419493670886	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	1648
148	61	7.24587702164677	61	0.3543	0.892419493670886	Central carbon metabolism in cancer	257
322	90	9.34493244957444	90	0.3559	0.892419493670886	Phosphatidylinositol signaling system	1179
793	19	3.35244971718514	19	0.3565	0.892419493670886	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	325
865	23	3.85258394233888	23	0.3571	0.892419493670886	Diseases associated with glycosaminoglycan metabolism	409
237	21	3.81987135328163	21	0.3573	0.892419493670886	Histidine metabolism	730
557	16	2.8208501251217	16	0.3574	0.892419493670886	Syndecan-1-mediated signaling events	1638
818	77	10.881389795461	77	0.3578	0.892419493670886	DNA Damage/Telomere Stress Induced Senescence	420
10	15	2.79568585671169	15	0.3585	0.892419493670886	TCA cycle	1677
1864	38	5.1210619160349	38	0.3586	0.892419493670886	tRNA modification in the nucleus and cytosol	1798
1363	26	4.43473052625051	26	0.3588	0.892419493670886	Phase 2 - plateau phase	1174
1487	78	8.9512776672529	78	0.3598	0.892419493670886	Regulation of APC/C activators between G1/S and early anaphase	1326
736	31	4.52547244793361	31	0.3603	0.892419493670886	Cargo concentration in the ER	222
1377	37	4.89436974019068	37	0.361	0.892419493670886	Platelet Aggregation (Plug Formation)	1216
664	93	10.2396250040142	93	0.3621	0.892419493670886	Antigen processing-Cross presentation	104
659	97	12.5352401819943	97	0.3628	0.892419493670886	Amyloid fiber formation	95
649	10	2.05814829809573	10	0.3635	0.892419493670886	Adenylate cyclase activating pathway	58
650	15	2.76944729938595	15	0.3636	0.892419493670886	Adenylate cyclase inhibitory pathway*	59
412	138	12.7389747226934	138	0.3648	0.892419493670886	Wnt signaling pathway	1860
839	10	2.12901016731741	10	0.3654	0.892419493670886	Defective EXT1 causes exostoses 1, TRPS2 and CHDS*	379
1353	13	2.66111785510182	13	0.3674	0.892419493670886	Passive transport by Aquaporins	1147
1249	12	2.38765754588049	12	0.3677	0.892419493670886	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	1053
1268	38	4.9447009451236	38	0.3684	0.892419493670886	Negative regulation of MAPK pathway	1033
1497	21	3.52766949111838	21	0.3691	0.892419493670886	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	1344
735	135	13.0996910107558	135	0.3695	0.892419493670886	Cardiac conduction	220
76	19	3.2565467959604	17	0.3697	0.892419493670886	Human Immunodeficiency Virus type 1 (ssRNA)	752
1134	20	3.24194895984997	20	0.3697	0.892419493670886	Intrinsic Pathway of Fibrin Clot Formation	839
546	50	5.81228369086828	50	0.3712	0.892419493670886	Signaling events mediated by PTP1B	1569
1819	16	2.85216813347625	16	0.3715	0.892419493670886	Vitamin B5 (pantothenate) metabolism	1850
279	85	8.90018546198915	85	0.372	0.892419493670886	Morphine addiction	987
985	63	7.24605008311861	63	0.3721	0.892419493670886	G1/S DNA Damage Checkpoints*	600
892	35	4.48642757545682	35	0.3724	0.892419493670886	EGFR interacts with phospholipase C-gamma	462
1719	13	2.39289693338678	13	0.3732	0.892419493670886	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	1743
63	78	7.92962232766631	73	0.3734	0.892419493670886	Adenovirus (dsDNA)	57
288	114	10.5766253065462	114	0.3735	0.892419493670886	Neurotrophin signaling pathway	1050
1312	83	8.52964852915419	83	0.3741	0.892419493670886	Opioid Signalling	1110
1304	13	2.42375121688711	13	0.3742	0.892419493670886	Nucleotide-like (purinergic) receptors	1098
1141	15	2.53978384639265	15	0.3745	0.892419493670886	JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1	856
1798	98	10.3726802921841	98	0.3755	0.892419493670886	UCH proteinases	1817
1644	72	7.78012273125517	72	0.3756	0.892419493670886	Signaling by TGF-beta Receptor Complex	1557
427	15	2.47208488315366	15	0.3766	0.892419493670886	Arf6 downstream pathway	128
869	41	5.02753823732319	41	0.3775	0.892419493670886	Diseases of metabolism	414
1235	30	4.15446507735364	30	0.3788	0.892419493670886	Molecules associated with elastic fibres	986
375	18	2.83515900747977	18	0.3792	0.892419493670886	Steroid biosynthesis	1608
1614	10	1.91421366234089	10	0.3793	0.892419493670886	Signaling by FGFR3 fusions in cancer	1525
1681	13	2.2898864523211	13	0.3795	0.892419493670886	Synthesis of PIPs at the early endosome membrane	1658
581	20	3.18454785341689	20	0.3797	0.892419493670886	p38 signaling mediated by MAPKAP kinases	1129
28	24	3.55338107345708	24	0.38	0.892419493670886	heparan sulfate biosynthesis	710
814	14	2.3588328174165	14	0.3803	0.892419493670886	DCC mediated attractive signaling	366
824	63	9.37508361731589	63	0.3803	0.892419493670886	DNA methylation	423
1323	92	9.43595126444151	92	0.3803	0.892419493670886	PCP/CE pathway	1155
1555	58	6.68854579982617	58	0.3809	0.892419493670886	SCF(Skp2)-mediated degradation of p27/p21	1477
175	78	7.61951271903628	78	0.3812	0.892419493670886	EGFR tyrosine kinase inhibitor resistance	463
1321	62	7.13456592510605	62	0.3812	0.892419493670886	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	1125
1586	24	3.40989442658825	24	0.3816	0.892419493670886	Sema4D induced cell migration and growth-cone collapse	1484
1815	50	6.1775218621389	50	0.3816	0.892419493670886	Vif-mediated degradation of APOBEC3G	1842
843	11	2.10622979845922	11	0.3819	0.892419493670886	Defects in cobalamin (B12) metabolism	383
39	10	1.84259889514275	10	0.382	0.892419493670886	purine nucleotides degradation	1284
479	30	3.8711565538055	30	0.3823	0.892419493670886	HIF-2-alpha transcription factor network	726
1556	53	6.46665618069117	53	0.3823	0.892419493670886	SCF-beta-TrCP mediated degradation of Emi1	1476
1740	58	6.64899599743804	58	0.3832	0.892419493670886	The role of GTSE1 in G2/M progression after G2 checkpoint	1699
1576	45	5.24874397525457	45	0.3835	0.892419493670886	SUMOylation of DNA replication proteins	1618
162	27	3.67804055401386	27	0.3836	0.892419493670886	Collecting duct acid secretion	310
860	17	2.8300870467592	17	0.3838	0.892419493670886	Digestion of dietary lipid	403
163	59	6.2216540071567	59	0.3842	0.892419493670886	Colorectal cancer	311
34	25	3.42158910119348	25	0.3852	0.892419493670886	mucin core 1 and core 2 O-glycosylation	1001
1642	30	3.71831459734843	30	0.3862	0.892419493670886	Signaling by Robo receptor	1555
1340	16	2.51525231504533	16	0.3865	0.892419493670886	PKA activation	1207
1590	15	2.36221656072831	15	0.3867	0.892419493670886	Serotonin Neurotransmitter Release Cycle	1490
1279	10	1.83293917470297	10	0.387	0.892419493670886	Neurotoxicity of clostridium toxins	1046
1645	284	21.2948032016935	287	0.3884	0.892419493670886	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)*	1559
1346	35	4.06252671745927	35	0.3886	0.892419493670886	PLC-gamma1 signalling	1223
731	10	1.90311212590393	10	0.389	0.892419493670886	Calcitonin-like ligand receptors	208
423	54	5.63442996614029	54	0.39	0.892419493670886	ATF-2 transcription factor network	144
456	33	3.89990934697464	33	0.3906	0.892419493670886	E-cadherin signaling in the nascent adherens junction	450
1636	11	1.96481662486644	11	0.3906	0.892419493670886	Signaling by NOTCH4	1549
753	72	7.73616729925805	72	0.3907	0.892419493670886	Cellular response to hypoxia*	253
1473	32	3.89939516125189	32	0.3907	0.892419493670886	ROS, RNS production in phagocytes	1457
1807	13	2.13216343985061	13	0.391	0.892419493670886	Uptake and function of anthrax toxins	1822
1167	290	23.3706504066143	290	0.3916	0.892419493670886	M Phase	901
1159	10	1.78956484337809	10	0.3919	0.892419493670886	Ligand-independent caspase activation via DCC	881
548	36	4.23216072388174	36	0.3929	0.892419493670886	Signaling events mediated by TCPTP	1571
487	60	6.20484516290134	60	0.3935	0.892419493670886	IL12-mediated signaling events	770
1049	218	17.0384204805895	218	0.3942	0.892419493670886	HIV Infection	733
1216	14	2.19919020681352	14	0.3949	0.892419493670886	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	966
141	10	1.70559116736623	10	0.3969	0.892419493670886	C5 isoprenoid biosynthesis, mevalonate pathway*	204
1230	166	13.4110907309679	166	0.3971	0.892419493670886	Mitotic Metaphase and Anaphase*	981
1635	11	1.92214113456706	11	0.3979	0.892419493670886	Signaling by NOTCH3	1548
67	17	2.71582616156301	13	0.3982	0.892419493670886	Enterovirus 71 (ssRNA)	479
1502	28	3.41810885863646	28	0.3987	0.892419493670886	Regulation of TNFR1 signaling	1364
1853	51	5.88801298447579	51	0.3987	0.892419493670886	p53-Independent DNA Damage Response*	1135
145	69	6.95825007041006	69	0.3989	0.892419493670886	Cardiac muscle contraction	221
3	17	2.48330949747389	17	0.399	0.892419493670886	3-phosphoinositide degradation	4
207	110	9.57847280801523	110	0.399	0.892419493670886	Glutamatergic synapse	646
1431	109	9.15942319145195	109	0.3999	0.892419493670886	RHO GTPases Activate Formins	1405
1664	52	5.72681205126272	52	0.4003	0.892419493670886	Stabilization of p53	1604
1476	10	1.75993189288872	10	0.4004	0.892419493670886	Reactions specific to the complex N-glycan synthesis pathway	1309
1721	35	4.62561255791955	35	0.4008	0.892419493670886	TRAF6 mediated IRF7 activation	1747
258	64	6.23626950487151	64	0.4018	0.892419493670886	Long-term potentiation	889
847	55	6.05952154759278	55	0.4026	0.892419493670886	Degradation of DVL	388
1402	29	3.62375136695063	29	0.4032	0.892419493670886	Processing of Capped Intronless Pre-mRNA	1254
446	48	4.87457055923512	48	0.4038	0.892419493670886	Caspase cascade in apoptosis	227
365	107	9.54513199672722	107	0.4039	0.892419493670886	Serotonergic synapse	1489
1169	58	5.7989686497997	58	0.4048	0.892419493670886	MAP kinase activation in TLR cascade	907
473	37	3.9928566356242	37	0.405	0.892419493670886	FOXM1 transcription factor network	578
152	176	14.7107424454016	176	0.4053	0.892419493670886	Chemokine signaling pathway	267
1449	62	8.06927810627039	62	0.4058	0.892419493670886	RNA Polymerase I Promoter Opening	1429
513	21	2.64784115498923	21	0.4062	0.892419493670886	PDGFR-alpha signaling pathway	1157
1667	24	3.01824365488528	24	0.4074	0.892419493670886	Sulfur amino acid metabolism	1613
1717	19	2.46790350064548	19	0.4076	0.892419493670886	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	1742
1058	97	8.58756037657324	97	0.4077	0.892419493670886	Hedgehog 'off' state	702
1663	16	2.23492104377395	16	0.4081	0.892419493670886	Spry regulation of FGF signaling	1601
615	107	9.07709901158402	107	0.4083	0.892419493670886	Activated TLR4 signalling	20
1070	133	11.2986021722445	133	0.4083	0.892419493670886	Homology Directed Repair*	740
460	17	2.23095285436506	17	0.4095	0.892419493670886	EPHA2 forward signaling	484
82	11	1.73980750977538	10	0.4096	0.892419493670886	JC Virus (dsDNA)	855
1284	26	3.22329639299971	26	0.4099	0.892419493670886	Nicotinate metabolism	1058
981	48	4.88544549979659	48	0.4105	0.892419493670886	G-protein beta:gamma signalling	596
165	43	4.55703766738466	43	0.4121	0.892419493670886	Cysteine and methionine metabolism	349
910	17	2.3946448999894	17	0.4123	0.892419493670886	Elevation of cytosolic Ca2+ levels	467
13	12	1.68397643991635	12	0.4133	0.892419493670886	bile acid biosynthesis, neutral pathway	184
529	71	6.27215567748932	71	0.4133	0.892419493670886	Regulation of Wnt-mediated beta catenin signaling and target gene transcription	1372
1037	52	4.86024933469983	52	0.4134	0.892419493670886	Golgi Associated Vesicle Biogenesis	678
773	68	6.10060863019296	68	0.4141	0.892419493670886	Clathrin derived vesicle budding*	299
208	51	5.28665633948704	51	0.4147	0.892419493670886	Glutathione metabolism	648
1737	23	2.77689187919126	23	0.4164	0.892419493670886	The canonical retinoid cycle in rods (twilight vision)	1695
425	46	4.28759698384713	46	0.4179	0.892419493670886	Angiopoietin receptor Tie2-mediated signaling	99
1813	42	4.15322440631668	42	0.4179	0.892419493670886	Vasopressin regulates renal water homeostasis via Aquaporins	1832
772	348	23.2134604200825	348	0.418	0.892419493670886	Class I MHC mediated antigen processing & presentation	296
553	34	3.53202368659609	34	0.4182	0.892419493670886	Signaling mediated by p38-alpha and p38-beta	1575
1187	86	9.27815488107113	86	0.4185	0.892419493670886	Meiotic recombination	920
70	95	7.6051014034701	91	0.419	0.892419493670886	Hepatitis B virus (dsDNART)	715
653	13	1.71319408916582	13	0.419	0.892419493670886	Advanced glycosylation endproduct receptor signaling	67
874	29	3.20875728835137	29	0.4192	0.892419493670886	Downregulation of ERBB2 signaling	432
1728	12	1.88799604720494	12	0.4194	0.892419493670886	Tandem pore domain potassium channels	1671
699	215	16.8201164892049	215	0.4205	0.892712878787879	Biological oxidations	187
312	109	8.72653478280439	109	0.4206	0.892712878787879	Parkinson's disease	1146
1806	31	3.34667363584126	31	0.4213	0.893070996216898	Uptake and actions of bacterial toxins	1821
1140	42	4.08622677043571	42	0.4225	0.894005513784461	Iron uptake and transport	849
495	43	4.13320894377765	43	0.4229	0.894005513784461	Insulin Pathway	804
828	22	2.52788426698041	22	0.4237	0.894005513784461	Deadenylation of mRNA	368
364	15	1.84759287189207	15	0.4241	0.894005513784461	Selenocompound metabolism	1479
1232	136	11.6936838910094	136	0.4244	0.894005513784461	Mitotic Prophase	983
1111	27	2.82921242552635	27	0.4251	0.894091033623911	Integrin alphaIIb beta3 signaling	813
138	39	3.85122028449489	39	0.4259	0.894091033623911	Bladder cancer	192
110	43	4.02203224898278	43	0.4266	0.894091033623911	Aminoacyl-tRNA biosynthesis	91
1366	10	1.40157246627518	10	0.4267	0.894091033623911	Phenylalanine and tyrosine catabolism	1177
449	12	1.62877652852803	12	0.4271	0.894091033623911	Circadian rhythm pathway	288
846	53	5.04563157580503	53	0.4338	0.902744092570037	Degradation of AXIN	386
543	38	3.58264724818904	38	0.4339	0.902744092570037	Signaling events mediated by HDAC Class III	1566
318	80	6.13959191918756	80	0.4342	0.902744092570037	Peroxisome	1169
1824	25	2.64205565648734	25	0.435	0.902744092570037	WNT ligand biogenesis and trafficking	1858
1240	93	7.35611853356579	93	0.4352	0.902744092570037	MyD88-independent TLR3/TLR4 cascade*	1009
1110	107	8.23132383905813	107	0.4361	0.902744092570037	Integration of energy metabolism	812
691	24	2.51412985035776	24	0.4365	0.902744092570037	Basigin interactions	172
895	34	3.18610774538381	34	0.4369	0.902744092570037	EPHA-mediated growth cone collapse	483
1406	14	1.72598981573755	14	0.4369	0.902744092570037	Processive synthesis on the lagging strand	1258
1415	10	1.26826824229911	10	0.4373	0.902744092570037	Purine catabolism	1279
210	86	6.9466091741668	86	0.4383	0.902744092570037	Glycerophospholipid metabolism	653
5	14	1.66087036581086	14	0.4388	0.902744092570037	D-myo-inositol (1,3,4)-trisphosphate biosynthesis	358
654	20	2.24826259372209	20	0.4391	0.902744092570037	Aflatoxin activation and detoxification	68
1472	27	2.66410333809925	27	0.4392	0.902744092570037	RORA activates gene expression	1456
1129	27	2.74463628368175	27	0.4399	0.902744092570037	Interleukin-7 signaling	832
955	26	2.60844584933109	26	0.4405	0.902744092570037	Fertilization*	543
1514	12	1.56923051629239	12	0.4407	0.902744092570037	Regulation of gene expression by Hypoxia-inducible Factor	1335
852	13	1.61698488121129	13	0.4409	0.902744092570037	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	393
418	78	6.00365233648145	78	0.4422	0.903818347509113	mRNA surveillance pathway	996
319	74	5.77863449320701	74	0.4425	0.903818347509113	Pertussis	1170
1394	18	1.90569254022827	18	0.4445	0.906075241545894	Pre-NOTCH Processing in Golgi	1242
1404	20	2.22889497825308	20	0.4447	0.906075241545894	Processing of Intronless Pre-mRNAs	1256
604	53	4.7130868262644	53	0.4453	0.906075241545894	AUF1 (hnRNP D0) binds and destabilizes mRNA	150
1258	15	1.73391222978728	15	0.4462	0.906075241545894	NRIF signals cell death from the nucleus	1085
1554	19	1.99732776637956	19	0.4463	0.906075241545894	SALM protein interactions at the synapses	1471
642	30	2.872644185356	30	0.4474	0.907212786489747	Activation of the pre-replicative complex	45
286	122	9.62806585125196	122	0.45	0.911385542168675	Natural killer cell mediated cytotoxicity	1021
1059	82	6.56673937233397	82	0.4534	0.914608602150538	Hedgehog 'on' state	703
1373	19	2.00469912035511	19	0.4539	0.914608602150538	Phosphorylation of the APC/C	1188
751	190	13.615477041905	190	0.4544	0.914608602150538	Cellular Senescence	256
977	45	3.63955668197437	45	0.4545	0.914608602150538	G beta:gamma signalling through PI3Kgamma	592
1820	43	3.4672175108994	43	0.4548	0.914608602150538	Voltage gated Potassium channels	1854
1412	15	1.61253300967852	15	0.4549	0.914608602150538	Protein methylation	1271
392	162	10.5963384998892	162	0.4554	0.914608602150538	Tight junction	1711
497	45	3.25787845410181	45	0.4573	0.916294201183432	Integrins in angiogenesis	815
651	26	2.26557809489206	26	0.458	0.916294201183432	Adherens junctions interactions	61
1352	36	3.08528213974043	36	0.4595	0.916294201183432	Paradoxical activation of RAF signaling by kinase inactive BRAF*	1145
1588	107	8.45059401776308	107	0.4595	0.916294201183432	Senescence-Associated Secretory Phenotype (SASP)	1487
1161	70	5.04476143723155	70	0.4596	0.916294201183432	Lipoprotein metabolism	884
517	22	1.87193047610714	22	0.4603	0.916294201183432	Paxillin-independent events mediated by a4b1 and a4b7	1153
1825	13	1.34897535392536	13	0.4604	0.916294201183432	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	1861
992	10	1.11355260752945	10	0.4606	0.916294201183432	GABA A receptor activation	607
81	105	7.54259958534736	97	0.4624	0.917030237825595	Influenza virus (ssRNA)	792
665	291	17.2083915245558	291	0.4626	0.917030237825595	Antigen processing: Ubiquitination & Proteasome degradation	105
744	488	28.873702913123	488	0.4631	0.917030237825595	Cell Cycle, Mitotic	245
1627	20	1.66577215020801	20	0.4634	0.917030237825595	Signaling by NODAL	1540
430	14	1.40797804994425	14	0.4637	0.917030237825595	Atypical NF-kappaB pathway	149
199	81	5.32540566286016	81	0.4647	0.917030237825595	GABAergic synapse	611
409	194	12.4862930000442	194	0.467	0.917030237825595	Viral carcinogenesis	1843
681	64	4.88592779572341	64	0.4682	0.917030237825595	Asymmetric localization of PCP proteins	143
1147	212	16.4860802124804	212	0.4685	0.917030237825595	Keratinization	863
1074	40	2.9378265154106	40	0.4686	0.917030237825595	Host Interactions with Influenza Factors*	744
1186	117	8.37720855590627	117	0.4692	0.917030237825595	Meiosis	919
1656	250	16.8117339421525	290	0.47	0.917030237825595	Signalling to ERKs*	1578
716	13	1.17000701495033	13	0.471	0.917030237825595	CLEC7A (Dectin-1) induces NFAT activation	302
447	22	1.83909776076017	22	0.4713	0.917030237825595	Cellular roles of Anthrax toxin	255
810	33	2.30634838684233	33	0.4716	0.917030237825595	DAG and IP3 signaling	362
523	29	2.16965108688997	29	0.4719	0.917030237825595	Reelin signaling pathway	1318
878	92	6.16552295185554	92	0.4721	0.917030237825595	Downstream TCR signaling	443
1388	22	1.78851392213066	22	0.4726	0.917030237825595	Post-chaperonin tubulin folding pathway	1232
1125	258	14.9647931534684	258	0.4727	0.917030237825595	Interleukin-3, 5 and GM-CSF signaling	828
287	256	14.3311180661358	256	0.4729	0.917030237825595	Neuroactive ligand-receptor interaction	1043
1175	10	1.03413694986011	10	0.4735	0.917030237825595	MAPK3 (ERK1) activation	914
357	95	6.08356637953715	95	0.4747	0.917030237825595	Retrograde endocannabinoid signaling	1396
1067	11	1.03672370218453	11	0.4749	0.917030237825595	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	727
1780	201	12.0488493589096	201	0.4749	0.917030237825595	Transmission across Chemical Synapses	1775
1498	16	1.35550286897786	16	0.4751	0.917030237825595	Regulation of KIT signaling	1345
118	31	2.07451147291022	31	0.4761	0.917030237825595	Apoptosis - multiple species	117
404	59	3.87562044164469	59	0.4765	0.917030237825595	VEGF signaling pathway	1834
1495	26	2.24116940271487	26	0.4773	0.917030237825595	Regulation of IFNA signaling	1340
1179	11	0.980245538858644	11	0.4778	0.917030237825595	MET activates RAP1 and RAC1	928
612	10	0.9173629276515	10	0.479	0.917030237825595	Acetylcholine regulates insulin secretion	15
887	32	2.17513167665962	32	0.4793	0.917030237825595	E2F mediated regulation of DNA replication	451
1018	33	2.22506468116152	33	0.4793	0.917030237825595	Glucagon signaling in metabolic regulation	632
1505	14	1.17116043141285	14	0.4796	0.917030237825595	Regulation of TP53 Activity through Association with Co-factors	1367
470	47	2.90150178277708	47	0.4804	0.917030237825595	FGF signaling pathway	544
1081	10	0.890933045820485	10	0.4809	0.917030237825595	IRAK4 deficiency (TLR2/4)*	846
970	25	1.86609756202133	25	0.4812	0.917030237825595	Formation of tubulin folding intermediates by CCT/TriC	575
726	22	1.73097263917287	22	0.4816	0.917030237825595	CTLA4 inhibitory signaling	341
459	31	2.09710943678502	31	0.4817	0.917030237825595	EPHA forward signaling	482
902	74	5.26693229528562	74	0.4826	0.917704298642534	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	504
747	127	7.37808684874818	127	0.4842	0.919047855530474	Cell surface interactions at the vascular wall	248
675	275	15.0054090808177	275	0.4844	0.919047855530474	Asparagine N-linked glycosylation	136
1371	192	10.3371111290335	192	0.4855	0.919495768374165	Phospholipid metabolism	1186
1863	42	2.70215748294513	42	0.4868	0.919495768374165	tRNA Aminoacylation	1797
284	85	4.86292145700739	85	0.4877	0.919495768374165	NF-kappa B signaling pathway	1052
1698	227	13.1345136233051	227	0.4881	0.919495768374165	TCF dependent signaling in response to WNT	1678
1838	22	1.49117314022781	22	0.4883	0.919495768374165	eNOS activation and regulation*	478
1170	36	2.38863827948842	36	0.4898	0.919495768374165	MAP2K and MAPK activation	908
472	44	2.54123200617778	44	0.4904	0.919495768374165	FOXA2 and FOXA3 transcription factor networks	577
250	43	2.94048927532542	43	0.4906	0.919495768374165	Intestinal immune network for IgA production	834
1618	11	0.91141734768968	11	0.4908	0.919495768374165	Signaling by FGFR4 in disease	1529
891	24	1.70642107771136	24	0.491	0.919495768374165	EGFR downregulation	461
8	15	0.952343397801606	15	0.4912	0.919495768374165	D-myo-inositol-5-phosphate metabolism	361
873	19	1.27184791932057	19	0.4912	0.919495768374165	Dopamine Neurotransmitter Release Cycle	429
1218	21	1.44050856938683	21	0.4918	0.91959488320356	Mitochondrial Fatty Acid Beta-Oxidation	969
1826	15	1.0489165748315	15	0.493	0.919823925027563	WNT5A-dependent internalization of FZD4	1862
1093	361	18.8873186871631	361	0.4932	0.919823925027563	Infectious disease	784
708	21	1.38414547573178	21	0.4954	0.919823925027563	CD209 (DC-SIGN) signaling	229
1374	12	0.852800698763056	12	0.4954	0.919823925027563	Physiological factors	1191
1128	11	0.805459628828727	11	0.4957	0.919823925027563	Interleukin-6 signaling	831
1120	90	5.33223879965883	90	0.496	0.919823925027563	Interferon gamma signaling	822
1435	17	1.26634500799734	17	0.496	0.919823925027563	RHO GTPases activate CIT	1404
295	48	2.72814457912814	48	0.4963	0.919823925027563	Notch signaling pathway (KEGG)	1077
1320	123	7.48765403513645	123	0.4973	0.920662224669604	Oxidative Stress Induced Senescence	1124
975	139	7.12975726063013	139	0.4998	0.924272607260726	G alpha (s) signalling events	590
1565	67	4.23305333455144	67	0.5009	0.925288901098901	SIRT1 negatively regulates rRNA Expression	1583
211	35	2.0491931663116	35	0.5015	0.925380351262349	Glycine, serine and threonine metabolism	654
849	58	3.56869157154969	59	0.503	0.92713048245614	Degradation of GLI2 by the proteasome*	390
714	29	1.44049018892471	29	0.5057	0.930876344086021	CDO in myogenesis*	238
1753	88	4.68814398729678	88	0.5066	0.930876344086021	Toll Like Receptor 9 (TLR9) Cascade*	1727
570	22	1.20107844957712	22	0.5071	0.930876344086021	VEGFR3 signaling in lymphatic endothelium	1839
1591	11	0.687695497133854	11	0.5085	0.930876344086021	Serotonin receptors	1491
161	47	2.49093771714316	47	0.5097	0.930876344086021	Cocaine addiction	305
952	14	0.83140947171226	14	0.5097	0.930876344086021	Fatty acids	530
1035	38	2.04219255014019	38	0.51	0.930876344086021	Glycosphingolipid metabolism	672
216	23	1.30493450081327	23	0.511	0.930876344086021	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	664
533	53	2.65815149769003	53	0.511	0.930876344086021	Regulation of retinoblastoma protein	1358
854	66	3.82449885498761	66	0.5119	0.930876344086021	Deposition of new CENPA-containing nucleosomes at the centromere*	395
355	20	1.11990697045019	20	0.5126	0.930876344086021	Renin-angiotensin system	1378
94	93	4.62492311307971	93	0.5129	0.930876344086021	AGE-RAGE signaling pathway in diabetic complications	70
850	79	3.99755854219216	79	0.5133	0.930876344086021	Degradation of beta-catenin by the destruction complex	387
1500	67	3.46683241269079	67	0.5135	0.930876344086021	Regulation of RAS by GAPs	1357
742	585	29.6259064889903	585	0.5141	0.930876344086021	Cell Cycle	243
1213	17	0.932337564137126	17	0.5145	0.930876344086021	Miscellaneous transport and binding events	962
1148	41	2.09035881567509	41	0.5148	0.930876344086021	Kinesins	864
837	17	0.897700047831223	17	0.515	0.930876344086021	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)*	377
781	21	1.00480483997213	21	0.5168	0.932856748140276	Common Pathway of Fibrin Clot Formation	312
737	91	4.35886985883182	91	0.5173	0.932856748140276	Cargo recognition for clathrin-mediated endocytosis	223
1283	15	0.903465890515504	15	0.5181	0.932856748140276	Nicotinamide salvaging	1056
539	28	1.29586478122595	28	0.519	0.932856748140276	S1P3 pathway	1465
226	37	1.95240847307131	37	0.5203	0.932856748140276	Graft-versus-host disease	684
1541	40	1.86248816919789	40	0.5213	0.932856748140276	Retinoid metabolism and transport	1393
290	35	1.64070379280872	35	0.5214	0.932856748140276	Nicotine addiction	1059
870	351	16.8739879519681	351	0.5214	0.932856748140276	Diseases of signal transduction	415
1600	57	2.66206562721993	57	0.5214	0.932856748140276	Signaling by BRAF and RAF fusions	1510
673	51	2.18696424282246	51	0.5217	0.932856748140276	Aquaporin-mediated transport	124
1342	17	0.739675679255969	17	0.5222	0.932856748140276	PKA-mediated phosphorylation of CREB	1209
727	11	0.359693585763599	11	0.5236	0.934086956521739	CYP2E1 reactions	348
1381	87	3.97475963335059	87	0.524	0.934086956521739	Platelet homeostasis	1219
928	74	3.60251046864769	74	0.5248	0.934522033898305	FCERI mediated NF-kB activation	539
530	19	0.731496215359958	19	0.5272	0.936886800422387	Regulation of cytoplasmic and nuclear SMAD2/3 signaling	1332
1679	12	0.586646150091858	12	0.5277	0.936886800422387	Synthesis of PE	1657
1652	32	1.42590134890667	32	0.5278	0.936886800422387	Signaling by high-kinase activity BRAF mutants	1532
1005	10	0.305399528134085	10	0.5291	0.936936315789474	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	614
1536	93	3.6426437624585	93	0.5294	0.936936315789474	Resolution of Sister Chromatid Cohesion	1386
376	55	2.23203538494172	55	0.5295	0.936936315789474	Steroid hormone biosynthesis	1609
1714	12	0.442913739237788	12	0.5301	0.93701167192429	TP53 Regulates Transcription of Death Receptors and Ligands	1738
475	46	1.68836165282172	46	0.5311	0.937514690451207	FoxO family signaling	579
1002	15	0.505689727536255	15	0.5315	0.937514690451207	GRB2:SOS provides linkage to MAPK signaling for Integrins	687
466	100	4.30279478436025	100	0.5321	0.937589203354298	ErbB1 downstream signaling	499
1208	34	1.50739417551232	34	0.5334	0.93791359832636	Metalloprotease DUBs	951
1846	15	0.543222932754672	15	0.5334	0.93791359832636	mRNA decay by 5' to 3' exoribonuclease	991
705	12	0.240673384676104	12	0.5341	0.938163113897597	Butyrophilin (BTN) family interactions	200
493	56	2.22959978808622	56	0.5356	0.938558333333333	IL4-mediated signaling events	776
758	12	0.49493673521018	12	0.5359	0.938558333333333	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	269
1300	25	0.928924755135309	25	0.536	0.938558333333333	Nuclear signaling by ERBB4	1093
1699	110	4.65830607108351	110	0.5375	0.939005561277034	TCR signaling	1679
1733	25	0.869915045837272	25	0.5383	0.939005561277034	Termination of O-glycan biosynthesis	1684
1407	166	6.96527697397706	166	0.5387	0.939005561277034	Programmed Cell Death*	1260
789	20	0.613949662984029	20	0.5394	0.939005561277034	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants*	321
230	44	1.71290731295853	44	0.5398	0.939005561277034	Hedgehog signaling pathway	706
532	26	1.01250815767651	26	0.5411	0.939005561277034	Regulation of p38-alpha and p38-beta	1353
756	95	3.81811877820186	95	0.5411	0.939005561277034	Chaperonin-mediated protein folding	264
464	26	0.920403933227267	26	0.5416	0.939005561277034	Ephrin B reverse signaling	487
564	41	1.24298169444853	41	0.5417	0.939005561277034	TNF receptor signaling pathway	1713
1118	196	8.50164720427476	196	0.542	0.939005561277034	Interferon Signaling	823
168	34	1.19496447998574	34	0.5424	0.939005561277034	DNA replication	425
858	273	12.4722927718084	273	0.5431	0.939250102880658	Deubiquitination	400
728	29	0.848823376946932	29	0.544	0.939839671120247	Ca-dependent events	205
795	31	1.07120644850959	31	0.5454	0.941153531218014	Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding	327
378	10	0.218074738929658	10	0.5465	0.941153531218014	Synthesis and degradation of ketone bodies	1642
986	113	4.81140058456509	113	0.547	0.941153531218014	G1/S Transition	601
1153	19	0.51770341173283	19	0.547	0.941153531218014	Lagging Strand Synthesis	868
718	80	2.76601887629655	80	0.5488	0.94204612244898	COPI-dependent Golgi-to-ER retrograde traffic	328
740	12	0.255020398661048	12	0.5491	0.94204612244898	Caspase-mediated cleavage of cytoskeletal proteins	228
1682	46	1.49265408813467	46	0.5492	0.94204612244898	Synthesis of PIPs at the plasma membrane	1660
36	27	0.633732126431894	27	0.5506	0.942695213849287	protein ubiquitylation	1274
1349	71	2.19360958895063	71	0.5507	0.942695213849287	PRC2 methylates histones and DNA	1240
1440	81	2.78105167239335	81	0.5516	0.943066598984771	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	1418
571	79	2.47786662563399	79	0.5522	0.943066598984771	Validated targets of C-MYC transcriptional activation	1825
1004	33	0.803495736090111	33	0.5526	0.943066598984771	Gamma carboxylation, hypusine formation and arylsulfatase activation	613
613	30	0.844605660987955	30	0.5548	0.944286437246964	Activated NOTCH1 Transmits Signal to the Nucleus	16
701	10	0.142933198139697	10	0.5548	0.944286437246964	Biotin transport and metabolism	191
768	18	0.371315079478283	18	0.555	0.944286437246964	Citric acid cycle (TCA cycle)	292
1438	21	0.396487132898936	21	0.5568	0.946391102123357	RHO GTPases activate PAKs	1409
1568	272	10.5624732264193	272	0.5584	0.946579233870968	SLC-mediated transmembrane transport	1586
717	95	3.359381848141	95	0.5586	0.946579233870968	CLEC7A (Dectin-1) signaling	303
957	37	0.958254229944833	37	0.5586	0.946579233870968	Formation of Fibrin Clot (Clotting Cascade)	563
1659	35	0.859185096624843	35	0.5598	0.947657401812689	Smooth Muscle Contraction	1589
1364	19	0.450681817479735	19	0.5608	0.948286733668342	Phase 4 - resting membrane potential	1175
764	100	3.1285635486387	100	0.5613	0.948286733668342	Chromosome Maintenance	281
1204	30	0.523923751139571	30	0.5622	0.948853614457831	Metabolism of steroid hormones	946
1833	16	0.186923759545046	16	0.5638	0.949152047952048	activated TAK1 mediates p38 MAPK activation	19
605	70	2.01424375091462	70	0.5645	0.949152047952048	AURKA Activation by TPX2*	151
549	63	1.5707246377272	63	0.5648	0.949152047952048	Signaling events mediated by VEGFR1 and VEGFR2	1573
909	41	1.14642262683882	41	0.5651	0.949152047952048	Elastic fibre formation	466
866	22	0.383028825756002	22	0.5652	0.949152047952048	Diseases associated with the TLR signaling cascade*	411
614	65	1.26470537637757	65	0.5664	0.949723184079602	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	17
428	34	0.559455304454327	34	0.567	0.949723184079602	Arf6 signaling events	129
1777	62	1.61124864363088	62	0.5674	0.949723184079602	Translocation of GLUT4 to the plasma membrane	1772
1712	42	0.749559218211153	42	0.5678	0.949723184079602	TP53 Regulates Transcription of Cell Death Genes	1737
499	13	0.065662855402652	13	0.57	0.952455268389662	JNK signaling in the CD4+ TCR pathway	857
238	35	0.439870528795863	35	0.5708	0.952844885799404	Homologous recombination	739
608	10	-0.0961124584452189	10	0.5736	0.955053353057199	Abacavir transport and metabolism	7
54	15	0.0110256615136386	15	0.5739	0.955053353057199	superpathway of pyrimidine deoxyribonucleoside salvage	1629
732	27	0.269032220591599	27	0.5743	0.955053353057199	Calmodulin induced events*	211
844	17	0.0781964386875427	17	0.5755	0.955053353057199	Defects in vitamin and cofactor metabolism	384
968	71	1.30072907904201	71	0.5755	0.955053353057199	Formation of the cornified envelope	571
755	77	2.08578405979405	77	0.5759	0.955053353057199	Centrosome maturation*	258
356	59	0.960006981564959	59	0.5761	0.955053353057199	Retinol metabolism	1395
50	63	1.07346796261809	63	0.5768	0.955271724137931	superpathway of inositol phosphate compounds	1625
220	15	-0.113985713633497	15	0.5782	0.955801467710372	Glycosphingolipid biosynthesis - ganglio series	669
444	22	0.112628451333295	22	0.5784	0.955801467710372	Canonical NF-kappaB pathway	215
1527	13	0.00894008660152308	13	0.5798	0.955801467710372	Removal of the Flap Intermediate	1374
80	183	5.39338593319115	167	0.5801	0.955801467710372	Human papillomavirus (dsDNA)	754
400	45	0.548492427213543	45	0.5806	0.955801467710372	Type II diabetes mellitus	1809
1443	77	1.33198452732287	77	0.5807	0.955801467710372	RMTs methylate histone arginines	1421
1307	63	1.02464717669467	63	0.5811	0.955801467710372	O-linked glycosylation of mucins	1102
485	33	0.292775739181013	33	0.5851	0.958088792270531	IL1-mediated signaling events	768
1605	43	0.461411299007102	43	0.5853	0.958088792270531	Signaling by ERBB4	1516
1426	24	0.186235486071807	24	0.5855	0.958088792270531	RAF activation	1301
1544	33	0.26385248995781	33	0.5861	0.958088792270531	Rev-mediated nuclear export of HIV RNA	1399
277	22	-0.0692483392337928	22	0.5866	0.958088792270531	Mismatch repair	963
247	102	2.1100882777607	102	0.587	0.958088792270531	Insulin resistance	808
121	18	-0.0355865402796501	18	0.5872	0.958088792270531	Arginine biosynthesis	132
535	40	0.412990173262098	40	0.5872	0.958088792270531	RhoA signaling pathway	1413
159	21	-0.0801740266979142	21	0.5887	0.958088792270531	Citrate cycle (TCA cycle, Krebs cycle)	289
976	48	0.595081475938437	48	0.5887	0.958088792270531	G alpha (z) signalling events	591
66	16	-0.124373296869829	16	0.5894	0.958088792270531	Ebola Virus (ssRNA)	456
1212	12	-0.295232570902711	12	0.5895	0.958088792270531	Miscellaneous substrates	961
572	60	0.730897171310912	60	0.5899	0.958088792270531	Validated targets of C-MYC transcriptional repression	1826
1116	33	0.252710652971105	33	0.5914	0.959597876447877	Interactions of Vpr with host cellular proteins*	820
177	94	1.75500255277954	94	0.5925	0.960178131021195	Endocrine resistance	469
1231	101	1.68326650394079	101	0.5929	0.960178131021195	Mitotic Prometaphase	982
1123	46	0.378320276695103	46	0.5936	0.960386525505294	Interleukin-10 signaling	826
1736	12	-0.191587684983814	12	0.5949	0.960656510186005	The NLRP3 inflammasome	1697
156	93	1.82914143050434	93	0.595	0.960656510186005	Circadian entrainment	286
1229	176	5.07933992356841	176	0.5968	0.960656510186005	Mitotic G2-G2/M phases*	980
783	48	0.167655264938889	48	0.5973	0.960656510186005	Complex I biogenesis	315
1145	12	-0.402770060424851	12	0.5975	0.960656510186005	Keratan sulfate degradation	861
386	88	1.37854202793918	88	0.5986	0.960656510186005	Th1 and Th2 cell differentiation	1693
586	17	-0.406923085599427	17	0.5987	0.960656510186005	ABC transporters in lipid homeostasis	10
345	65	0.4674399389415	65	0.5993	0.960656510186005	RIG-I-like receptor signaling pathway	1417
140	27	-0.171208004836193	27	0.6006	0.960656510186005	Butanoate metabolism	198
469	33	-0.338384967113061	33	0.601	0.960656510186005	FAS (CD95) signaling pathway	521
1727	24	-0.0947140072492129	24	0.6014	0.960656510186005	TRP channels	1801
962	16	-0.348966892264994	16	0.6017	0.960656510186005	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	568
379	124	1.13654554846179	124	0.6019	0.960656510186005	Systemic lupus erythematosus	1667
593	25	-0.13897497234345	25	0.602	0.960656510186005	APC-Cdc20 mediated degradation of Nek2A	109
114	28	-0.285120639711878	28	0.6026	0.960656510186005	Antifolate resistance	100
305	100	1.67916681609966	100	0.603	0.960656510186005	Oxidative phosphorylation	1123
519	46	0.360381567998894	46	0.6036	0.960656510186005	Presenilin action in Notch and Wnt signaling	1245
505	22	-0.374741437999171	22	0.6067	0.960656510186005	Nectin adhesion pathway	1024
1195	49	0.139639743447637	49	0.6069	0.960656510186005	Metabolism of fat-soluble vitamins	937
1594	33	-0.191039247724353	33	0.6069	0.960656510186005	Signal amplification	1501
489	28	-0.307015177936944	28	0.6074	0.960656510186005	IL2 signaling events mediated by STAT5	772
491	37	-0.286865531565883	37	0.6081	0.960656510186005	IL23-mediated signaling events	774
657	26	-0.333562979697775	26	0.6085	0.960656510186005	Amino acid synthesis and interconversion (transamination)	88
696	10	-0.393511461688558	10	0.6088	0.960656510186005	Bicarbonate transporters	181
173	45	-0.556288433868833	45	0.6094	0.960656510186005	Drug metabolism - other enzymes	445
687	23	-0.285554778422303	23	0.6097	0.960656510186005	BBSome-mediated cargo-targeting to cilium	173
244	162	3.46535968312098	162	0.6101	0.960656510186005	Influenza A	788
1028	14	-0.352090837186903	14	0.6104	0.960656510186005	Glutathione synthesis and recycling	649
339	197	4.29805749799856	197	0.6116	0.960656510186005	Proteoglycans in cancer	1276
848	58	0.585284650921565	58	0.612	0.960656510186005	Degradation of GLI1 by the proteasome	389
1765	104	0.336746816734731	104	0.6142	0.960656510186005	Transcriptional regulation by small RNAs	1759
96	52	-0.228257576456833	52	0.6149	0.960656510186005	Acute myeloid leukemia	47
545	23	-0.63382543139977	23	0.6163	0.960656510186005	Signaling events mediated by PRL	1568
1599	22	-0.391090849249542	22	0.6164	0.960656510186005	Signaling by BMP	1509
1849	15	-0.660657524134404	15	0.6177	0.960656510186005	p130Cas linkage to MAPK signaling for integrins	1127
309	61	0.0358052818405829	61	0.6199	0.960656510186005	Pancreatic cancer	1142
1151	23	-0.501267951117937	23	0.6203	0.960656510186005	LDL-mediated lipid transport	871
262	11	-0.510815229134617	11	0.6213	0.960656510186005	Lysine degradation, lysine => saccharopine => acetoacetyl-CoA	898
71	18	-0.580509521605535	16	0.6217	0.960656510186005	Hepatitis C Virus (dsDNA)	717
1665	97	1.06901554476467	97	0.6226	0.960656510186005	Stimuli-sensing channels	1610
58	30	-0.601801941156078	30	0.6232	0.960656510186005	superpathway of tryptophan utilization	1633
396	12	-0.647821870338056	12	0.6237	0.960656510186005	Triacylglycerol biosynthesis	1789
1068	41	-0.516421050929633	41	0.6244	0.960656510186005	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	731
380	97	0.738939986654492	97	0.6246	0.960656510186005	T cell receptor signaling pathway	1668
826	11	-0.669380683283095	11	0.6254	0.960656510186005	DSCAM interactions	446
1234	12	-0.675723712897409	12	0.626	0.960656510186005	Mitotic Telophase/Cytokinesis	985
803	69	0.42063877219463	71	0.6263	0.960656510186005	Cyclin E associated events during G1/S transition*	347
116	135	1.89186077191221	135	0.6266	0.960656510186005	Apelin signaling pathway	116
1026	23	-0.832354468272767	23	0.6271	0.960656510186005	Glutamate Neurotransmitter Release Cycle	645
275	271	6.07155476393708	271	0.6273	0.960656510186005	MicroRNAs in cancer	959
627	31	-0.587911847327562	31	0.6274	0.960656510186005	Activation of Kainate Receptors upon glutamate binding	33
1543	45	-0.692081702204727	45	0.6274	0.960656510186005	Retrograde transport at the Trans-Golgi-Network	1398
488	36	-0.550338639411487	36	0.6276	0.960656510186005	IL2 signaling events mediated by PI3K	771
1048	37	-0.594152232371019	37	0.6282	0.960656510186005	HDR through Single Strand Annealing (SSA)	701
1439	91	-0.829342297907966	91	0.6282	0.960656510186005	RHO GTPases activate PKNs	1410
445	29	-0.519659603656448	29	0.6283	0.960656510186005	Canonical Wnt signaling pathway	216
686	92	-0.893967679201843	92	0.6284	0.960656510186005	B-WICH complex positively regulates rRNA expression	164
362	86	-0.0230539884830457	86	0.6289	0.960656510186005	Salivary secretion	1470
1837	12	-0.713489894822024	12	0.6298	0.960656510186005	eNOS activation	477
1253	28	-0.766085938665247	28	0.6303	0.960656510186005	NOD1/2 Signaling Pathway	1064
509	17	-0.628098555874642	17	0.6306	0.960656510186005	Nongenotropic Androgen signaling	1070
1709	78	0.224631478222608	78	0.6311	0.960656510186005	TP53 Regulates Metabolic Genes	1733
948	151	1.68584927528217	151	0.6322	0.960656510186005	Factors involved in megakaryocyte development and platelet production	518
761	46	-0.838730248803399	46	0.6323	0.960656510186005	Chondroitin sulfate/dermatan sulfate metabolism	278
853	14	-0.664679888198953	14	0.6329	0.960656510186005	Depolymerisation of the Nuclear Lamina	394
1850	13	-0.651524970862283	13	0.6333	0.960656510186005	p38MAPK events	1130
574	21	-0.674518194345253	21	0.6335	0.960656510186005	Visual signal transduction: Cones	1848
1278	328	7.73847400128946	328	0.6338	0.960656510186005	Neuronal System	1045
100	66	0.115958081773433	66	0.6347	0.960656510186005	Adipocytokine signaling pathway	62
652	28	-0.748028083203078	28	0.6349	0.960656510186005	Adrenaline,noradrenaline inhibits insulin secretion	65
224	28	-0.817150091831587	28	0.6356	0.960656510186005	Glyoxylate and dicarboxylate metabolism	674
1796	11	-0.777656777899067	11	0.6357	0.960656510186005	Tryptophan catabolism	1804
1158	20	-1.23788992529364	20	0.6366	0.960656510186005	Ligand-gated ion channel transport	880
1791	37	-1.02777282801455	37	0.6366	0.960656510186005	Transport of vitamins, nucleosides, and related molecules	1786
134	12	-0.762480306075145	12	0.637	0.960656510186005	Bile acid biosynthesis, cholesterol => cholate/chenodeoxycholate	183
468	32	-0.915243838176482	32	0.639	0.960656510186005	ErbB4 signaling events	503
1690	62	-0.549170327577342	62	0.6407	0.960656510186005	Synthesis of substrates in N-glycan biosythesis	1662
1009	29	-0.904418992440171	29	0.6408	0.960656510186005	Gap junction trafficking and regulation	620
525	25	-0.991285493516323	25	0.6413	0.960656510186005	Regulation of CDC42 activity	1329
1418	12	-0.785978821529061	12	0.6429	0.960656510186005	Purine salvage	1286
203	63	-0.700785093699016	63	0.6433	0.960656510186005	Glioma	630
1607	62	-0.47354714430395	62	0.6436	0.960656510186005	Signaling by FGFR in disease	1518
259	87	-0.140037898968979	87	0.6439	0.960656510186005	Longevity regulating pathway	890
53	27	-1.1399772712094	27	0.644	0.960656510186005	superpathway of purine nucleotide salvage	1628
439	69	-0.316609279240357	69	0.644	0.960656510186005	CDC42 signaling events	235
83	79	-0.372829474390505	77	0.6447	0.960656510186005	Kaposi's Sarcoma-associated Virus (dsDNA)	859
269	101	0.0455204050855522	101	0.6448	0.960656510186005	Melanogenesis	922
588	25	-1.01222317759985	25	0.6448	0.960656510186005	ADP signalling through P2Y purinoceptor 1	63
749	54	-1.25615033953618	54	0.6448	0.960656510186005	Cell-cell junction organization	250
1411	101	0.173189620551326	101	0.6452	0.960656510186005	Protein folding	1270
27	11	-0.999817508825431	11	0.6461	0.961145221238938	guanosine ribonucleotides de novo biosynthesis	693
857	34	-1.10819995006964	34	0.6496	0.964525	Detoxification of Reactive Oxygen Species	399
411	23	-1.02726143300355	23	0.6509	0.964525	Vitamin digestion and absorption	1851
1433	17	-1.05470583321182	17	0.6512	0.964525	RHO GTPases Activate ROCKs	1411
1865	100	-0.0111650816852947	100	0.6513	0.964525	tRNA processing	1799
658	27	-1.34833742678131	27	0.6517	0.964525	Amino acid transport across the plasma membrane	89
767	67	-0.621527060555769	67	0.6525	0.964525	Circadian Clock	285
274	11	-1.01049915633336	11	0.6531	0.964525	Methionine salvage pathway	954
1142	10	-0.779673749281477	10	0.6553	0.964525	Josephin domain DUBs	858
1683	15	-0.993311146317462	15	0.6553	0.964525	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	1661
680	15	-0.878030553710158	15	0.6556	0.964525	Association of licensing factors with the pre-replicative complex	140
1634	32	-1.02660739508493	32	0.6558	0.964525	Signaling by NOTCH2	1547
1799	205	2.45327208614965	205	0.6567	0.964525	Ub-specific processing proteases	1811
157	30	-1.1686484085633	30	0.6568	0.964525	Circadian rhythm	287
1069	42	-1.32944453432557	42	0.6569	0.964525	Homologous DNA Pairing and Strand Exchange	738
1477	29	-1.18227081244748	29	0.6578	0.964525	Recognition of DNA damage by PCNA-containing replication complex	1311
403	125	0.301902794373684	125	0.6582	0.964525	Ubiquitin mediated proteolysis	1814
382	105	-0.352973736435536	105	0.6585	0.964525	TNF signaling pathway	1716
1457	142	0.738549484400062	142	0.6587	0.964525	RNA Polymerase II Transcription	1438
268	125	-0.147727701158253	125	0.6606	0.965508375634518	Measles	918
688	45	-1.33435161010124	45	0.6606	0.965508375634518	BMAL1:CLOCK,NPAS2 activates circadian gene expression	193
679	39	-1.48201164368802	39	0.6622	0.965508375634518	Association of TriC/CCT with target proteins during biosynthesis	141
502	14	-1.14070146806966	14	0.6625	0.965508375634518	LPA4-mediated signaling events	895
1255	21	-1.22696563469892	21	0.6636	0.965508375634518	NOTCH2 Activation and Transmission of Signal to the Nucleus	1082
272	72	-2.90695097805073	72	0.6642	0.965508375634518	Metabolism of xenobiotics by cytochrome P450	949
1041	134	-2.05689151879323	134	0.6645	0.965508375634518	HATs acetylate histones	694
1358	83	-1.02859857184627	83	0.6652	0.965508375634518	Peptide hormone metabolism	1165
1785	30	-1.34344606431768	30	0.6657	0.965508375634518	Transport of Ribonucleoproteins into the Host Nucleus	1783
1675	27	-1.41283576237999	27	0.6665	0.965508375634518	Synthesis of IP3 and IP4 in the cytosol	1653
1302	109	-0.377569927804211	109	0.6672	0.965508375634518	Nucleotide Excision Repair	1096
583	54	-1.27399109135863	54	0.6675	0.965508375634518	p75(NTR)-mediated signaling	1138
1759	14	-1.18001177793989	14	0.6692	0.965508375634518	Trafficking of GluR2-containing AMPA receptors	1751
1269	20	-1.27407499492578	20	0.6693	0.965508375634518	Negative regulation of MET activity	1034
1103	12	-1.1740887787407	12	0.6702	0.965508375634518	Initiation of Nuclear Envelope Reformation*	798
1115	35	-1.48664014913548	35	0.6703	0.965508375634518	Interactions of Rev with host cellular proteins	819
26	14	-1.50794985930218	14	0.671	0.965508375634518	guanosine nucleotides de novo biosynthesis	692
1088	112	-2.03917913412574	112	0.6713	0.965508375634518	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	779
1810	28	-1.55925972389018	28	0.6713	0.965508375634518	VEGFR2 mediated vascular permeability	1838
759	22	-1.52274962129901	22	0.6718	0.965508375634518	Cholesterol biosynthesis	270
1160	111	-1.34254532236112	111	0.6719	0.965508375634518	Lipid digestion, mobilization, and transport	883
332	70	-1.39260913216451	70	0.6725	0.965508375634518	Prolactin signaling pathway	1262
1311	71	-1.35450210561343	71	0.6727	0.965508375634518	Oncogenic MAPK signaling	1107
1804	83	-1.20672416002299	83	0.6754	0.965508375634518	Unfolded Protein Response (UPR)	1819
622	13	-1.22088146475338	13	0.6755	0.965508375634518	Activation of DNA fragmentation factor*	27
876	22	-1.33718971660438	22	0.6756	0.965508375634518	Downregulation of SMAD2/3:SMAD4 transcriptional activity	434
1731	23	-1.61567219319897	23	0.6761	0.965508375634518	Telomere C-strand (Lagging Strand) Synthesis	1682
182	81	-1.55262998580914	81	0.6764	0.965508375634518	ErbB signaling pathway	498
78	13	-1.42364618688255	11	0.6768	0.965508375634518	Human T-lymphotropic virus (dsDNA)	755
1414	65	-1.81579538000651	65	0.6781	0.965508375634518	Protein-protein interactions at synapses	1275
1256	12	-1.22285617345948	12	0.6784	0.965508375634518	NOTCH2 intracellular domain regulates transcription	1083
1704	37	-1.73662932421699	37	0.6786	0.965508375634518	TNF signaling	1715
32	10	-1.20530990386647	10	0.6788	0.965508375634518	melatonin degradation I*	924
139	141	-0.495300068978491	141	0.6789	0.965508375634518	Breast cancer	196
372	125	-0.793438183441228	125	0.6811	0.966857996632997	Spliceosome	1600
390	112	-0.738070027514218	112	0.6824	0.966857996632997	Thyroid hormone signaling pathway	1707
1492	30	-1.64706122621742	30	0.6824	0.966857996632997	Regulation of Glucokinase by Glucokinase Regulatory Protein	1337
544	71	-1.92512933680064	71	0.6828	0.966857996632997	Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)	1567
11	10	-1.39306334392446	10	0.683	0.966857996632997	UTP and CTP de novo biosynthesis	1823
1082	52	-1.57462363054202	52	0.6833	0.966857996632997	IRE1alpha activates chaperones*	847
172	66	-3.76736445280565	66	0.6844	0.967383849372385	Drug metabolism - cytochrome P450	444
1043	20	-1.53640622389731	20	0.6851	0.967383849372385	HDL-mediated lipid transport	696
1399	39	-1.96283479012097	39	0.6865	0.967383849372385	Presynaptic phase of homologous DNA pairing and strand exchange	1248
534	25	-1.73686477896749	25	0.6867	0.967383849372385	Retinoic acid receptors-mediated signaling	1392
799	48	-1.841547051683	48	0.687	0.967383849372385	Cross-presentation of soluble exogenous antigens (endosomes)	339
923	28	-1.7826911725593	28	0.6872	0.967383849372385	Extension of Telomeres	515
1763	39	-1.89752561023476	39	0.6877	0.967383849372385	Transcriptional activation of mitochondrial biogenesis	1756
609	25	-1.86184642968986	25	0.6888	0.9677335839599	Abortive elongation of HIV-1 transcript in the absence of Tat	12
462	32	-1.93504609902547	32	0.6891	0.9677335839599	EPO signaling pathway	491
1523	12	-1.39807219675329	12	0.6898	0.967908013355593	Regulation of pyruvate dehydrogenase (PDH) complex	1355
720	78	-1.67077936862551	78	0.6908	0.968502752293578	COPI-mediated anterograde transport	330
512	31	-2.15831111138933	31	0.692	0.968754074074074	Osteopontin-mediated events	1117
105	81	-2.20865898098229	81	0.6932	0.968754074074074	Aldosterone synthesis and secretion	74
1691	22	-1.80193342224274	22	0.6932	0.968754074074074	Synthesis of very long-chain fatty acyl-CoAs	1663
1297	34	-1.94876517793989	34	0.6947	0.968754074074074	Nuclear Pore Complex (NPC) Disassembly	1091
1735	12	-1.50322253670666	12	0.6949	0.968754074074074	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1687
1261	10	-1.33609442573313	10	0.695	0.968754074074074	Nef Mediated CD4 Down-regulation	1025
9	11	-1.5559758287208	11	0.6959	0.968754074074074	NAD de novo biosynthesis	1020
914	27	-1.90424047862667	27	0.696	0.968754074074074	Energy dependent regulation of mTOR by LKB1-AMPK	476
1720	16	-1.76893591214238	16	0.6971	0.968754074074074	TRAF3-dependent IRF activation pathway	1744
496	29	-2.10662949711775	29	0.6995	0.968754074074074	Insulin-mediated glucose transport	811
183	98	-1.80620076537037	98	0.6997	0.968754074074074	Estrogen signaling pathway	508
1034	116	-2.14776764464173	116	0.6999	0.968754074074074	Glycosaminoglycan metabolism	668
1397	21	-1.89819756977065	21	0.7	0.968754074074074	Presynaptic function of Kainate receptors*	1246
960	41	-2.15055340931989	41	0.7001	0.968754074074074	Formation of Incision Complex in GG-NER	566
1250	12	-1.45832333375735	12	0.7001	0.968754074074074	NF-kB is activated and signals survival	1054
1207	24	-2.03405559223199	24	0.7002	0.968754074074074	Metal ion SLC transporters	950
1361	45	-2.89357030641105	45	0.7029	0.971488798037612	Phase 0 - rapid depolarisation	1172
229	247	0.843969655943587	247	0.7039	0.971488798037612	HTLV-I infection	749
494	42	-2.27694352499458	42	0.7043	0.971488798037612	IL6-mediated signaling events	777
193	37	-2.28451288031936	37	0.7045	0.971488798037612	Ferroptosis	542
1479	11	-1.48616764291017	11	0.7052	0.971488798037612	Recruitment of NuMA to mitotic centrosomes	1314
47	23	-2.23639980508677	23	0.706	0.971488798037612	superpathway of cholesterol biosynthesis	1621
912	28	-2.02137100528865	28	0.7067	0.971488798037612	Endosomal Sorting Complex Required For Transport (ESCRT)	473
23	16	-2.19606678147697	16	0.7068	0.971488798037612	glutathione-mediated detoxification	650
1416	33	-2.40304906637419	33	0.7091	0.973853839869281	Purine metabolism (REACTOME)	1282
217	14	-1.8391762558577	14	0.7106	0.974733197389886	Glycosaminoglycan biosynthesis - keratan sulfate	665
371	16	-1.91986706807727	16	0.7109	0.974733197389886	Sphingosine biosynthesis	1599
508	29	-2.34482064338141	29	0.7129	0.97479217877095	Noncanonical Wnt signaling pathway	1069
1672	23	-2.31871959721423	23	0.7137	0.97479217877095	Synthesis and interconversion of nucleotide di- and triphosphates	1643
41	14	-2.0419396062095	14	0.7143	0.97479217877095	pyrimidine deoxyribonucleotides biosynthesis from CTP	1289
908	11	-2.17576246607626	11	0.7146	0.97479217877095	Eicosanoids	465
363	82	-2.89797370417967	82	0.7148	0.97479217877095	Salmonella infection	1472
1343	39	-2.53063733116584	39	0.7154	0.97479217877095	PKB-mediated events*	1210
1396	27	-2.58313578545466	27	0.7155	0.97479217877095	Prefoldin mediated transfer of substrate to CCT/TriC	1244
129	68	-2.84968636620495	68	0.7172	0.97479217877095	B cell receptor signaling pathway	163
1107	25	-2.21537553942149	25	0.7172	0.97479217877095	Insulin processing	805
1008	27	-2.6318230060661	27	0.7174	0.97479217877095	Gap junction trafficking	619
228	94	-2.74357497640708	94	0.7175	0.97479217877095	HIF-1 signaling pathway	724
192	86	-2.83286841457253	86	0.7186	0.97479217877095	Fc gamma R-mediated phagocytosis	535
915	17	-2.0629351411102	17	0.7189	0.97479217877095	Ephrin signaling	488
56	12	-2.08000885739598	12	0.7211	0.97479217877095	superpathway of pyrimidine ribonucleotides de novo biosynthesis	1631
595	23	-2.19211883071558	23	0.7212	0.97479217877095	APC/C:Cdc20 mediated degradation of Cyclin B	112
889	41	-2.94038248291386	41	0.7212	0.97479217877095	E3 ubiquitin ligases ubiquitinate target proteins	454
516	19	-2.24009270973421	19	0.7216	0.97479217877095	Paxillin-dependent events mediated by a4b1	1152
855	22	-2.43114996434846	22	0.7218	0.97479217877095	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models*	396
994	52	-3.49368647024055	52	0.7236	0.97479217877095	GABA receptor activation	609
794	43	-2.90576706213944	43	0.7244	0.97479217877095	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	326
158	28	-2.65363972545707	28	0.7245	0.97479217877095	Citrate cycle (TCA cycle)	290
429	43	-3.11708509217229	43	0.7246	0.97479217877095	Arf6 trafficking events	130
149	12	-1.87052215842125	12	0.7249	0.97479217877095	Ceramide biosynthesis	259
1597	20	-2.46578888342674	20	0.7258	0.97479217877095	Signal transduction by L1	1505
1519	86	-2.95518864941687	86	0.7262	0.97479217877095	Regulation of mRNA stability by proteins that bind AU-rich elements	1349
1299	32	-2.75060031080325	32	0.7264	0.97479217877095	Nuclear import of Rev protein	1090
754	427	2.62057000185623	427	0.7266	0.97479217877095	Cellular responses to stress	254
611	16	-2.46953323990636	16	0.7291	0.976721274900398	Acetylcholine Neurotransmitter Release Cycle	14
1036	24	-2.60869775632297	24	0.7292	0.976721274900398	Glyoxylate metabolism and glycine degradation	675
1228	137	-2.02529697919394	137	0.7298	0.976746656050955	Mitotic G1-G1/S phases	979
296	43	-3.11919426981233	43	0.7311	0.977648253968254	Nucleotide excision repair	1095
1474	16	-2.20884152897242	16	0.7325	0.977648253968254	Rap1 signalling	1305
661	10	-1.92219052547058	10	0.7326	0.977648253968254	Androgen biosynthesis	98
270	66	-3.57018508920579	66	0.7328	0.977648253968254	Melanoma	923
1050	140	-2.80189276599524	140	0.7339	0.977963708399366	HIV Life Cycle	734
506	25	-2.81215091878273	25	0.7342	0.977963708399366	Nephrin/Neph1 signaling in the kidney podocyte	1040
320	145	-4.01108445281152	145	0.7351	0.978387252573238	Phagosome	1171
674	57	-4.2920991004796	57	0.7386	0.97915949960907	Arachidonic acid metabolism (REACTOME)	126
1386	106	-6.55740476258586	106	0.7387	0.97915949960907	Positive epigenetic regulation of rRNA expression	1230
1639	47	-3.56653336095804	47	0.7388	0.97915949960907	Signaling by RAS mutants	1552
1506	19	-2.51154816742171	19	0.7404	0.97915949960907	Regulation of TP53 Activity through Methylation	1368
171	28	-3.06141734209971	28	0.7412	0.97915949960907	Dorso-ventral axis formation	431
1516	15	-2.23859988647235	15	0.7412	0.97915949960907	Regulation of innate immune responses to cytosolic DNA	1342
1165	12	-2.09009384149269	12	0.7419	0.97915949960907	Lysine catabolism	896
670	11	-2.14988354452605	11	0.7426	0.97915949960907	Apoptotic cleavage of cell adhesion proteins	121
451	33	-3.02711072926881	33	0.7427	0.97915949960907	Class I PI3K signaling events mediated by Akt	298
52	13	-2.19174110143623	13	0.7433	0.97915949960907	superpathway of methionine degradation	1627
249	132	-3.81263140620368	132	0.7436	0.97915949960907	Insulin signaling pathway	810
830	44	-3.59739118058998	44	0.7438	0.97915949960907	Death Receptor Signalling	370
1245	35	-3.14316977984705	35	0.7439	0.97915949960907	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	1018
1598	13	-2.27049562421963	13	0.7447	0.97915949960907	Signaling by Activin	1508
980	29	-3.15989431866222	29	0.7448	0.97915949960907	G-protein activation	595
1581	11	-2.08317718005753	11	0.745	0.97915949960907	SeMet incorporation into proteins	1486
1746	28	-3.52172843442824	28	0.7473	0.981415078125	Tight junction interactions	1712
402	11	-2.10072046451488	11	0.7484	0.98149976635514	Ubiquinone and other terpenoid-quinone biosynthesis	1812
55	19	-2.96955431178879	19	0.749	0.98149976635514	superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis	1630
222	26	-3.38501933827233	26	0.7497	0.98149976635514	Glycosphingolipid biosynthesis - lacto and neolacto series	671
294	57	-3.80638157576662	57	0.7497	0.98149976635514	Non-small cell lung cancer	1068
1726	10	-2.16141245722217	10	0.7513	0.98271835147745	TRIF-mediated programmed cell death	1791
167	61	-4.93862277904367	61	0.7518	0.98271835147745	Cytosolic DNA-sensing pathway	353
1280	135	-4.3345892214044	135	0.753	0.982778588052754	Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell	1047
620	31	-3.57920267901933	31	0.7535	0.982778588052754	Activation of BH3-only proteins	25
57	11	-2.17757094230531	11	0.7536	0.982778588052754	superpathway of steroid hormone biosynthesis	1632
1606	86	-4.52852289612088	86	0.7551	0.983971395348837	Signaling by FGFR	1517
1629	69	-3.96454862889339	69	0.7565	0.985032145623548	Signaling by NOTCH1	1542
458	25	-3.1482596550005	25	0.7576	0.98570092879257	EGF receptor (ErbB1) signaling pathway	460
907	14	-2.70785708518243	14	0.7584	0.985978654292343	Eicosanoid ligand-binding receptors	464
91	11	-2.2094629723732	11	0.7599	0.987165301391036	Varicella Zoster Virus (dsDNA)	1830
44	17	-3.03945168784753	17	0.7617	0.987916554809843	retinol biosynthesis	1394
281	47	-4.05687000251047	47	0.7626	0.987916554809843	N-Glycan biosynthesis	1015
1446	90	-8.42176029546028	90	0.7626	0.987916554809843	RNA Polymerase I Chain Elongation	1426
1612	42	-4.10814766513945	42	0.7631	0.987916554809843	Signaling by FGFR2 in disease	1523
565	24	-3.88061241981678	24	0.764	0.987916554809843	TRAIL signaling pathway	1752
1326	28	-3.62361131696882	28	0.7647	0.987916554809843	PERK regulates gene expression	1167
480	34	-3.82368042402271	34	0.7657	0.987916554809843	HIV-1 Nef: Negative effector of Fas and TNF-alpha	737
1535	26	-3.52813822652996	26	0.7667	0.987916554809843	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	1385
12	10	-2.63504398683696	10	0.7676	0.987916554809843	adenosine deoxyribonucleotides de novo biosynthesis*	56
885	40	-3.91946261540872	40	0.7677	0.987916554809843	Dual Incision in GG-NER	447
1094	17	-3.03466532605593	17	0.7685	0.987916554809843	Inflammasomes	785
723	26	-3.43522342235388	26	0.7689	0.987916554809843	CREB phosphorylation through the activation of Ras	337
1072	20	-3.44936953716605	20	0.7689	0.987916554809843	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	742
113	50	-4.72461592271869	50	0.7702	0.987916554809843	Amyotrophic lateral sclerosis (ALS)	96
160	14	-2.77067004597468	14	0.7713	0.987916554809843	Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate	291
1662	79	-5.37922612262889	79	0.773	0.987916554809843	Sphingolipid metabolism (REACTOME)	1596
1294	50	-4.54397648288719	50	0.7732	0.987916554809843	Nuclear Envelope Breakdown	1087
273	10	-2.42022444527498	10	0.7739	0.987916554809843	Methionine degradation	953
555	39	-4.27080794150674	39	0.7739	0.987916554809843	Stabilization and expansion of the E-cadherin adherens junction	1603
302	18	-3.21930327417543	18	0.775	0.987916554809843	Other glycan degradation	1118
440	33	-4.24640722374706	33	0.7753	0.987916554809843	CXCR3-mediated signaling events	342
1133	43	-4.60050073458842	43	0.7759	0.987916554809843	Intrinsic Pathway for Apoptosis	838
816	47	-4.6385528530973	47	0.7764	0.987916554809843	DNA Damage Bypass	418
1422	45	-4.45294998227001	45	0.7767	0.987916554809843	Pyruvate metabolism and Citric Acid (TCA) cycle	1296
492	26	-3.97429201990082	26	0.7774	0.987916554809843	IL27-mediated signaling events	775
42	14	-3.01645709075301	14	0.7777	0.987916554809843	pyrimidine deoxyribonucleotides de novo biosynthesis	1290
1042	91	-10.3583328881826	91	0.7778	0.987916554809843	HDACs deacetylate histones	695
37	11	-2.82580986981908	11	0.7782	0.987916554809843	purine deoxyribonucleosides salvage	1280
1491	22	-3.57672206612447	22	0.7788	0.987916554809843	Regulation of FZD by ubiquitination	1334
808	19	-3.73383586824833	19	0.7792	0.987916554809843	Cytosolic sulfonation of small molecules	356
131	55	-5.23393100425039	55	0.7802	0.987916554809843	Basal cell carcinoma	167
573	32	-4.26244765068765	32	0.7802	0.987916554809843	Validated transcriptional targets of AP1 family members Fra1 and Fra2	1827
630	37	-4.10023158363755	37	0.7814	0.987916554809843	Activation of NMDA receptor upon glutamate binding and postsynaptic events	37
457	69	-5.31904310876468	69	0.7815	0.987916554809843	E2F transcription factor network	452
624	40	-4.63068896375257	40	0.7825	0.987916554809843	Activation of GABAB receptors*	29
554	21	-3.87108081278739	21	0.7834	0.987916554809843	Sphingosine 1-phosphate (S1P) pathway	1598
576	27	-4.06268754433454	27	0.7838	0.987916554809843	Wnt signaling network	1859
1030	14	-2.90287041078626	14	0.784	0.987916554809843	Glycogen breakdown (glycogenolysis)	655
1578	17	-3.13794974245328	17	0.7846	0.987916554809843	SUMOylation of transcription factors	1620
1417	12	-3.02294043259702	12	0.7851	0.987916554809843	Purine ribonucleoside monophosphate biosynthesis	1285
1537	88	-5.58737062881266	88	0.7851	0.987916554809843	Respiratory electron transport	1387
703	25	-3.83379981371945	25	0.7855	0.987916554809843	Budding and maturation of HIV virion	197
1303	44	-4.99840069373941	44	0.7866	0.987916554809843	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1097
1401	229	-4.79120907259572	229	0.787	0.987916554809843	Processing of Capped Intron-Containing Pre-mRNA	1253
1538	93	-5.84540917103224	93	0.7876	0.987916554809843	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	1388
194	138	-6.69785782805523	138	0.788	0.987916554809843	Fluid shear stress and atherosclerosis	558
935	32	-4.41909274863421	32	0.7881	0.987916554809843	FGFR2 mutant receptor activation	550
1710	11	-2.91628065094858	11	0.7894	0.988808792846498	TP53 Regulates Transcription of Caspase Activators and Caspases	1735
40	10	-2.82805645477997	10	0.7905	0.989449367088608	pyrimidine deoxyribonucleotide phosphorylation	1288
179	48	-4.90004448014678	48	0.7917	0.9902140625	Endometrial cancer	472
1010	25	-3.97413662044561	25	0.7937	0.991977472118959	Gap-filling DNA repair synthesis and ligation in GG-NER	621
1220	52	-5.29666056549631	52	0.7948	0.992002152932443	Mitochondrial protein import	970
385	22	-4.31834826798133	22	0.7949	0.992002152932443	Terpenoid backbone biosynthesis	1686
1150	91	-6.73600410502522	91	0.7955	0.992014465875371	L1CAM interactions	867
619	15	-3.38468666688654	15	0.7966	0.992649814677539	Activation of BAD and translocation to mitochondria	24
1583	87	-6.25179733055098	87	0.7996	0.993329468242245	Selenocysteine synthesis	1480
1831	10	-2.73214718684594	10	0.7996	0.993329468242245	Zinc influx into cells by the SLC39 gene family	1867
204	95	-6.50803266447129	95	0.7997	0.993329468242245	Glucagon signaling pathway	633
1499	85	-6.25036369383112	85	0.7999	0.993329468242245	Regulation of PLK1 Activity at G2/M Transition	1354
589	23	-4.23606258664585	23	0.8001	0.993329468242245	ADP signalling through P2Y purinoceptor 12	64
547	52	-5.44284969346255	52	0.8007	0.99334073800738	Signaling events mediated by Stem cell factor receptor (c-Kit)	1570
1582	111	-6.51548132767986	111	0.8013	0.993351991150442	Selenoamino acid metabolism	1478
95	117	-6.7046200956482	117	0.802	0.993487103905674	AMPK signaling pathway	94
983	25	-4.38580581624802	25	0.8036	0.994025569434239	G0 and Early G1	598
1574	105	-7.11867406212166	105	0.804	0.994025569434239	SUMOylation	1615
1027	38	-6.46734508232545	38	0.8048	0.994025569434239	Glutathione conjugation	647
1866	56	-5.92696754125876	56	0.8048	0.994025569434239	tRNA processing in the nucleus	1800
1742	32	-5.05112504138761	32	0.8063	0.994663609684519	Thrombin signalling through proteinase activated receptors (PARs)	1703
1327	74	-6.69701462918036	74	0.8065	0.994663609684519	PI Metabolism	1192
1859	52	-5.84472238643729	52	0.8077	0.994947208121827	rRNA modification in the nucleus and cytosol	1458
330	34	-5.46915794187049	34	0.8087	0.994947208121827	Prion diseases	1251
922	31	-4.81630945623823	31	0.8098	0.994947208121827	Export of Viral Ribonucleoproteins from Nucleus*	514
504	33	-5.05070011449051	33	0.81	0.994947208121827	N-cadherin signaling events	1012
1856	12	-3.27484683222162	12	0.8102	0.994947208121827	p75NTR recruits signalling complexes	1139
352	53	-5.73903434728856	53	0.8128	0.994947208121827	Regulation of lipolysis in adipocytes	1347
590	13	-3.54720186139789	13	0.8133	0.994947208121827	AKT phosphorylates targets in the cytosol	71
1475	18	-4.04707296184247	18	0.8135	0.994947208121827	Ras activation uopn Ca2+ infux through NMDA receptor	1306
1200	92	-7.02386051220551	92	0.8139	0.994947208121827	Metabolism of nucleotides	942
528	63	-6.27107605585569	63	0.8141	0.994947208121827	Regulation of Telomerase	1362
634	12	-3.29913760097395	12	0.8153	0.994947208121827	Activation of Rac	40
251	148	-10.3930340232727	148	0.8155	0.994947208121827	Jak-STAT signaling pathway	854
1611	19	-4.0234031692125	19	0.8155	0.994947208121827	Signaling by FGFR2 IIIa TM	1522
791	54	-6.22237668099935	54	0.8157	0.994947208121827	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants*	323
784	11	-3.24149697731644	11	0.8162	0.994947208121827	Condensation of Prometaphase Chromosomes	316
1156	13	-3.59460511459743	13	0.8162	0.994947208121827	Leading Strand Synthesis*	872
1743	23	-4.78707907831073	23	0.8172	0.995444347826087	Thromboxane signalling through TP receptor	1705
21	11	-3.32641468848229	11	0.8194	0.996202169197397	gamma-linolenate biosynthesis	615
1025	29	-5.20788223204058	29	0.8195	0.996202169197397	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity*	644
1263	108	-12.6996181418886	108	0.8196	0.996202169197397	Negative epigenetic regulation of rRNA expression*	1027
700	76	-7.45285149559852	76	0.8208	0.996462815884476	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	189
1104	14	-3.52580536832428	14	0.821	0.996462815884476	InlB-mediated entry of Listeria monocytogenes into host cell	799
301	123	-8.88952862094512	123	0.8224	0.997086301369863	Osteoclast differentiation	1116
500	41	-6.05667819515172	41	0.8227	0.997086301369863	LKB1 signaling events	887
511	46	-5.87109019108621	46	0.8241	0.997353021582734	Notch-mediated HES/HEY network	1080
1146	32	-5.84738663699173	32	0.8244	0.997353021582734	Keratan sulfate/keratin metabolism	862
956	10	-3.21297623118266	10	0.8247	0.997353021582734	Folding of actin by CCT/TriC	561
1766	37	-6.26702010488982	37	0.8259	0.997534906914894	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	1760
267	26	-5.32608609719239	26	0.8291	0.997534906914894	Maturity onset diabetes of the young	917
1053	32	-5.78179388510819	32	0.8299	0.997534906914894	HIV elongation arrest and recovery*	732
809	24	-5.14421883221415	24	0.8313	0.997534906914894	Cytosolic tRNA aminoacylation	357
919	88	-8.11911803450387	90	0.8314	0.997534906914894	Eukaryotic Translation Elongation*	511
1387	34	-5.70524941698274	34	0.8319	0.997534906914894	Post NMDA receptor activation events	1231
1676	22	-5.54623569777988	22	0.8323	0.997534906914894	Synthesis of Leukotrienes (LT) and Eoxins (EX)	1654
739	27	-5.79254639469248	27	0.833	0.997534906914894	Caspase activation via extrinsic apoptotic signalling pathway	226
1092	22	-5.21882495610681	22	0.8336	0.997534906914894	Incretin synthesis, secretion, and inactivation	783
1293	12	-3.65223743978382	12	0.834	0.997534906914894	Notch-HLH transcription pathway	1079
1152	15	-4.29738028045074	15	0.8349	0.997534906914894	LGI-ADAM interactions	878
334	83	-7.79591823977205	83	0.8358	0.997534906914894	Prostate cancer	1266
1410	19	-4.79322109623285	19	0.8359	0.997534906914894	Prostacyclin signalling through prostacyclin receptor	1265
17	15	-4.20454672644843	15	0.8365	0.997534906914894	chondroitin sulfate biosynthesis	276
1038	14	-4.10485619763694	14	0.8376	0.997534906914894	Golgi Cisternae Pericentriolar Stack Reorganization	679
1832	17	-4.40222078612454	17	0.8379	0.997534906914894	Zinc transporters	1868
1694	12	-3.88095578996304	12	0.838	0.997534906914894	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	1666
1114	28	-6.47488618138656	28	0.8383	0.997534906914894	Interaction between L1 and Ankyrins	816
346	69	-7.69362146543504	69	0.839	0.997534906914894	RNA degradation	1422
343	11	-4.07765622177124	11	0.8397	0.997534906914894	Pyrimidine ribonucleotide biosynthesis, UMP => UDP/UTP,CDP/CTP	1293
1521	13	-4.3694027595335	13	0.8411	0.997534906914894	Regulation of necroptotic cell death	1350
520	52	-7.47409094405717	52	0.8424	0.997534906914894	RAC1 signaling pathway	1300
370	117	-9.02120741962036	117	0.8443	0.997534906914894	Sphingolipid signaling pathway	1597
1144	27	-6.39076231994264	27	0.8451	0.997534906914894	Keratan sulfate biosynthesis	860
1031	14	-4.12121994463765	14	0.8453	0.997534906914894	Glycogen synthesis	656
1099	11	-3.80713554186752	11	0.8459	0.997534906914894	Inhibition of replication initiation of damaged DNA by RB1/E2F1	794
1464	18	-4.91579969386971	18	0.8461	0.997534906914894	RNA Polymerase III Chain Elongation	1445
1219	48	-7.08713711297008	48	0.8462	0.997534906914894	Mitochondrial biogenesis	968
1545	11	-4.33821086458199	11	0.8462	0.997534906914894	Reversible hydration of carbon dioxide	1400
829	53	-7.24758038921031	53	0.8468	0.997534906914894	Deadenylation-dependent mRNA decay	369
827	39	-6.63396263639588	39	0.8475	0.997534906914894	Deactivation of the beta-catenin transactivating complex	367
337	22	-5.11902690861479	22	0.8476	0.997534906914894	Protein export	1269
949	33	-6.2515001503174	33	0.8477	0.997534906914894	Fanconi Anemia Pathway	520
1857	15	-4.51025179837155	15	0.8494	0.997534906914894	p75NTR signals via NF-kB	1140
1610	73	-8.80123278706324	73	0.8501	0.997534906914894	Signaling by FGFR2	1521
1764	43	-7.05896308304205	43	0.8512	0.997534906914894	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	1757
206	27	-9.1650557079005	27	0.8514	0.997534906914894	Glucuronate pathway (uronate pathway)	642
438	28	-5.97280444562328	28	0.8519	0.997534906914894	CD40/CD40L signaling	233
185	47	-7.68993876801321	47	0.8522	0.997534906914894	Fanconi anemia pathway	519
1392	99	-10.3524133234936	99	0.8525	0.997534906914894	Potassium Channels	1236
1484	15	-4.99006666402536	15	0.8529	0.997534906914894	Regulated Necrosis*	1319
246	22	-5.50514181966844	22	0.8531	0.997534906914894	Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4	803
431	31	-6.10739909532548	31	0.8531	0.997534906914894	Aurora A signaling	152
1117	52	-7.95010815823915	52	0.8541	0.997534906914894	Interactions of neurexins and neuroligins at synapses	818
667	75	-8.96480508439198	75	0.8546	0.997534906914894	Antiviral mechanism by IFN-stimulated genes*	107
1842	182	-10.8971994128272	182	0.8553	0.997534906914894	mRNA Splicing*	993
1661	41	-7.42141867276908	41	0.8555	0.997534906914894	Sphingolipid de novo biosynthesis	1594
1122	41	-7.238116070225	41	0.8558	0.997534906914894	Interleukin-1 signaling	825
1573	99	-10.1384175240426	99	0.8559	0.997534906914894	SUMO E3 ligases SUMOylate target proteins	1614
1647	33	-6.75650707582512	33	0.8565	0.997534906914894	Signaling by WNT in cancer	1562
1135	31	-7.10067913946609	31	0.8566	0.997534906914894	Inwardly rectifying K+ channels	840
398	173	-13.83801896326	173	0.8583	0.997534906914894	Tuberculosis	1806
154	111	-10.2999042620412	111	0.8594	0.997534906914894	Cholinergic synapse	275
707	11	-4.39333633527232	11	0.8597	0.997534906914894	CASP8 activity is inhibited*	225
1006	18	-6.04199915267004	18	0.8603	0.997534906914894	Gap junction assembly	617
241	90	-10.8982619787826	90	0.8605	0.997534906914894	IL-17 signaling pathway	766
1803	15	-4.67477315375963	15	0.8606	0.997534906914894	Unblocking of NMDA receptor, glutamate binding and activation	1818
1155	127	-10.4024314824735	127	0.8611	0.997534906914894	Late Phase of HIV Life Cycle	870
790	15	-4.75232018801642	15	0.8621	0.997534906914894	Constitutive Signaling by NOTCH1 HD Domain Mutants*	322
132	41	-7.71408418434581	41	0.8627	0.997534906914894	Basal transcription factors	168
115	68	-12.4110496205424	68	0.8636	0.997534906914894	Antigen processing and presentation	103
1760	66	-9.06830840413601	66	0.864	0.997534906914894	Transcription of the HIV genome	1754
1273	35	-7.01552388236148	35	0.8642	0.997534906914894	Negative regulators of RIG-I/MDA5 signaling	1037
38	27	-6.90830956028043	27	0.8655	0.997534906914894	purine nucleotides de novo biosynthesis	1283
1761	78	-9.73285309736313	78	0.8659	0.997534906914894	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	1755
292	140	-10.8404915610815	140	0.866	0.997534906914894	Non-alcoholic fatty liver disease (NAFLD)	1065
1470	23	-6.05011606082984	23	0.8662	0.997534906914894	RNA Polymerase III Transcription Termination	1451
541	62	-8.75680792945304	62	0.8664	0.997534906914894	Signaling events mediated by HDAC Class I	1564
73	112	-11.0137370299687	105	0.8666	0.997534906914894	Herpes Simplex Virus (dsDNA)	720
1382	16	-5.13579154132185	16	0.8668	0.997534906914894	Platelet sensitization by LDL	1220
1575	73	-9.91424984844207	73	0.8684	0.997534906914894	SUMOylation of DNA damage response and repair proteins	1617
676	13	-4.46250221369141	13	0.8689	0.997534906914894	Assembly Of The HIV Virion	138
580	29	-6.81781206837122	29	0.8694	0.997534906914894	p38 MAPK signaling pathway	1128
601	25	-6.58393729794125	25	0.8705	0.997534906914894	ATF4 activates genes	145
483	40	-7.70906217096562	40	0.8711	0.997534906914894	IFN-gamma pathway	762
426	18	-5.56124983569716	18	0.8719	0.997534906914894	Arf1 pathway	127
786	24	-6.40515097733509	24	0.8738	0.997534906914894	Constitutive Signaling by AKT1 E17K in Cancer	319
443	27	-6.93266032304283	27	0.8743	0.997534906914894	Calcium signaling in the CD4+ TCR pathway	209
1383	17	-5.76667097912215	17	0.8751	0.997534906914894	Polo-like kinase mediated events	1225
1355	30	-7.34026040632754	30	0.8762	0.997534906914894	Pausing and recovery of Tat-mediated HIV elongation*	1151
298	406	-41.4423497850968	398	0.8775	0.997534906914894	Olfactory transduction	1105
1507	89	-10.891290951471	89	0.8783	0.997534906914894	Regulation of TP53 Activity through Phosphorylation	1369
315	34	-11.1807577347737	34	0.8787	0.997534906914894	Pentose and glucuronate interconversions	1160
393	99	-13.7208584526343	99	0.8787	0.997534906914894	Toll-like receptor signaling pathway	1730
476	80	-11.0878928279843	80	0.8795	0.997534906914894	Glucocorticoid receptor regulatory network	636
1713	61	-9.55393175957889	61	0.8796	0.997534906914894	TP53 Regulates Transcription of DNA Repair Genes	1739
800	22	-6.63093303410659	22	0.8797	0.997534906914894	Cyclin A/B1 associated events during G2/M transition	345
1162	19	-5.90087181864751	19	0.8797	0.997534906914894	Listeria monocytogenes entry into host cells	886
1450	109	-18.3103452591656	109	0.8799	0.997534906914894	RNA Polymerase I Transcription*	1430
963	53	-9.38182892731088	53	0.8808	0.997534906914894	Formation of TC-NER Pre-Incision Complex	569
1455	77	-10.6936032704855	77	0.8812	0.997534906914894	RNA Polymerase II Pre-transcription Events	1435
123	26	-10.6286998247207	26	0.8813	0.997534906914894	Ascorbate and aldarate metabolism	135
1254	44	-9.07375797784129	44	0.8822	0.997534906914894	NOTCH1 Intracellular Domain Regulates Transcription	1081
875	13	-4.89781528126806	13	0.8826	0.997534906914894	Downregulation of ERBB2:ERBB3 signaling	433
1421	25	-7.14699145484623	25	0.8829	0.997534906914894	Pyruvate metabolism (REACTOME)	1295
1344	64	-12.6422927425775	64	0.8832	0.997534906914894	PKMTs methylate histone lysines	1211
623	25	-7.40013626313851	25	0.8855	0.997534906914894	Activation of G protein gated Potassium channels*	28
60	16	-5.7196246325252	16	0.8856	0.997534906914894	triacylglycerol biosynthesis	1788
1113	10	-4.63168450820287	10	0.8861	0.997534906914894	Interaction With The Zona Pellucida	817
151	78	-17.1508903242194	78	0.8869	0.997534906914894	Chemical carcinogenesis	265
1289	108	-12.1690002906074	108	0.8877	0.997534906914894	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)*	1072
961	57	-9.93174311834508	57	0.8894	0.997534906914894	Formation of RNA Pol II elongation complex*	567
1738	134	-12.9480476954493	134	0.8894	0.997534906914894	The citric acid (TCA) cycle and respiratory electron transport	1696
1569	32	-8.00352257226343	32	0.8895	0.997534906914894	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	1587
1171	15	-5.61184788927332	15	0.8897	0.997534906914894	MAP3K8 (TPL2)-dependent MAPK1/3 activation	909
1436	13	-5.33625152682632	13	0.8903	0.997534906914894	RHO GTPases activate IQGAPs	1406
802	38	-8.55352874594548	38	0.8905	0.997534906914894	Cyclin D associated events in G1*	346
1044	45	-12.5926506091436	45	0.8909	0.997534906914894	HDMs demethylate histones	697
1786	101	-12.6055041703299	101	0.8912	0.997534906914894	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	1776
1202	16	-5.86989680007031	16	0.8917	0.997534906914894	Metabolism of porphyrins	944
567	32	-7.83505700788549	32	0.8918	0.997534906914894	Trk receptor signaling mediated by PI3K and PLC-gamma	1795
1772	18	-6.12695380233049	18	0.8922	0.997534906914894	Translesion Synthesis by POLH	1767
1190	11	-4.84528590996743	11	0.8923	0.997534906914894	Membrane binding and targetting of GAG proteins*	925
569	29	-7.7050360474181	29	0.8925	0.997534906914894	VEGFR1 specific signals	1836
1061	10	-4.69376808547842	10	0.8946	0.998991130091984	Heme biosynthesis	708
1071	11	-5.22499640896704	11	0.8957	0.998991130091984	Hormone ligand-binding receptors	741
1693	19	-6.84062478457257	19	0.8959	0.998991130091984	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	1665
1408	16	-6.99385476269962	16	0.8962	0.998991130091984	Prolactin receptor signaling	1261
1064	53	-10.0149339700216	53	0.8989	0.998991130091984	Hexose transport	721
1577	47	-10.5233062626165	47	0.899	0.998991130091984	SUMOylation of RNA binding proteins	1619
531	71	-11.0796276491765	71	0.8994	0.998991130091984	Regulation of nuclear SMAD2/3 signaling	1351
481	42	-9.50661860843959	42	0.8996	0.998991130091984	Hedgehog signaling events mediated by Gli proteins	705
49	12	-5.69612149127927	12	0.8997	0.998991130091984	superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate)	1624
556	11	-5.13099201338125	11	0.9007	0.998991130091984	Sumoylation by RanBP2 regulates transcriptional repression	1616
1080	15	-6.06126846258609	15	0.9014	0.998991130091984	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	845
1515	21	-7.27184161999169	21	0.9028	0.998991130091984	Regulation of gene expression in beta cells	1336
1309	380	-51.5408827387701	373	0.9036	0.998991130091984	Olfactory Signaling Pathway	1104
1325	11	-5.22659287118303	11	0.9037	0.998991130091984	PECAM1 interactions	1159
1469	28	-8.11254299939422	28	0.9037	0.998991130091984	RNA Polymerase III Transcription Initiation From Type 3 Promoter	1450
632	10	-5.22139844128349	10	0.9041	0.998991130091984	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	38
591	13	-5.65740302630492	13	0.9043	0.998991130091984	AMER1 mutants destabilize the destruction complex*	85
452	54	-10.546386086508	54	0.9045	0.998991130091984	Coregulation of Androgen receptor activity	332
239	168	-15.2839068871118	168	0.9057	0.999659684832567	Huntington's disease	757
344	38	-9.76754888132902	38	0.9074	0.999741396825397	Pyruvate metabolism (KEGG)	1294
1724	16	-6.50201775664389	16	0.9092	0.999741396825397	TRAF6 mediated induction of TAK1 complex	1746
1762	344	-17.2403036865477	344	0.9092	0.999741396825397	Transcriptional Regulation by TP53	1761
694	16	-6.74610263509415	16	0.9093	0.999741396825397	Beta-catenin phosphorylation cascade	178
916	146	-22.6751079406993	146	0.9104	0.999741396825397	Epigenetic regulation of gene expression	489
1489	26	-10.1693352169782	26	0.9106	0.999741396825397	Regulation of Complement cascade	1331
300	113	-14.5372644451751	113	0.9114	0.999741396825397	Oocyte meiosis	1109
1024	24	-12.33381532943	24	0.912	0.999741396825397	Glucuronidation	643
6	23	-8.07584012463155	23	0.9134	0.999741396825397	D-myo-inositol (1,4,5)-trisphosphate biosynthesis	359
1496	14	-6.28290651329353	14	0.9137	0.999741396825397	Regulation of IFNG signaling	1341
1509	36	-9.30115193399598	36	0.914	0.999741396825397	Regulation of TP53 Expression and Degradation*	1371
1794	17	-6.89632922699745	17	0.9145	0.999741396825397	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	1794
1776	39	-9.95949733310026	39	0.915	0.999741396825397	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	1771
1347	12	-6.02205705908308	12	0.9153	0.999741396825397	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	1237
448	43	-10.3629300939782	43	0.9156	0.999741396825397	Ceramide signaling pathway	260
1075	16	-7.36089672154936	16	0.9161	0.999741396825397	Hyaluronan metabolism	758
1217	14	-6.34311818748882	14	0.9174	0.999741396825397	Misspliced GSK3beta mutants stabilize beta-catenin*	967
1413	58	-12.5715841259331	58	0.9182	0.999741396825397	Protein ubiquitination	1273
1774	17	-7.03936279650703	17	0.9194	0.999741396825397	Translesion synthesis by POLK	1769
862	30	-9.13415685021602	30	0.9196	0.999741396825397	Disassembly of the destruction complex and recruitment of AXIN to the membrane	407
1078	23	-8.36255285309965	23	0.9199	0.999741396825397	IKK complex recruitment mediated by RIP1	765
316	25	-8.68984817821903	25	0.9213	0.999741396825397	Pentose phosphate pathway	1161
326	71	-15.6601115048673	71	0.9226	0.999741396825397	Platinum drug resistance	1221
1076	12	-6.8924760836912	12	0.9232	0.999741396825397	Hyaluronan uptake and degradation	759
1290	89	-14.6236900351904	89	0.9243	0.999741396825397	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1073
1700	14	-6.92774225410527	14	0.9244	0.999741396825397	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	1688
1512	33	-9.86049418443934	33	0.9246	0.999741396825397	Regulation of beta-cell development	1328
1157	17	-7.58211123807057	17	0.9247	0.999741396825397	Ligand-dependent caspase activation	879
1571	105	-15.1810714086507	105	0.9249	0.999741396825397	SRP-dependent cotranslational protein targeting to membrane	1602
626	18	-7.27419183752326	18	0.9254	0.999741396825397	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	32
437	22	-8.20322689557988	22	0.9262	0.999741396825397	C-MYC pathway	202
327	39	-14.8841026548948	39	0.9264	0.999741396825397	Porphyrin and chlorophyll metabolism	1229
1339	29	-9.12494518493885	29	0.9267	0.999741396825397	PIWI-interacting RNA (piRNA) biogenesis	1206
921	87	-14.6517595138122	87	0.9278	0.999741396825397	Eukaryotic Translation Termination	513
1127	27	-9.69384698533788	27	0.928	0.999741396825397	Interleukin-6 family signaling	830
1023	45	-11.3400305619069	45	0.9282	0.999741396825397	Glucose transport	641
1775	16	-7.4113154300448	16	0.9297	0.999741396825397	Translesion synthesis by REV1	1770
245	67	-13.5220499420261	67	0.9311	0.999741396825397	Inositol phosphate metabolism (KEGG)	801
965	35	-10.737754089523	35	0.9315	0.999741396825397	Formation of the Early Elongation Complex*	572
2	27	-9.87217846334309	27	0.9322	0.999741396825397	3-phosphoinositide biosynthesis	3
48	32	-10.2275721318471	32	0.9323	0.999741396825397	superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle	1622
636	119	-28.18413813377	119	0.9323	0.999741396825397	Activation of anterior HOX genes in hindbrain development during early embryogenesis*	21
1365	106	-24.0922482597866	106	0.9336	0.999741396825397	Phase II conjugation	1176
1773	17	-7.87788844151502	17	0.9338	0.999741396825397	Translesion synthesis by POLI	1768
1095	147	-17.8579188909677	147	0.934	0.999741396825397	Influenza Infection	789
958	44	-12.0786982744425	44	0.9349	0.999741396825397	Formation of HIV elongation complex in the absence of HIV Tat*	564
374	33	-12.0753249701945	33	0.9358	0.999741396825397	Starch and sucrose metabolism	1606
1734	33	-10.7573876809765	33	0.9363	0.999741396825397	Termination of translesion DNA synthesis	1685
75	33	-12.5465275409245	28	0.9365	0.999741396825397	Human Immunodeficiency Virus type 1 (dsDNA)	751
143	42	-13.1320782646311	42	0.9365	0.999741396825397	Carbohydrate digestion and absorption	218
253	68	-17.2030832191453	68	0.9366	0.999741396825397	Leishmaniasis	874
1097	128	-17.0347932067593	128	0.9367	0.999741396825397	Influenza Viral RNA Transcription and Replication	791
260	61	-13.6313170752801	61	0.9379	0.9999	Longevity regulating pathway - multiple species	891
733	26	-9.35755173953982	26	0.94	0.9999	Calnexin/calreticulin cycle	212
762	251	-32.6903984104828	251	0.9401	0.9999	Chromatin modifying enzymes*	279
568	28	-10.1380264463404	28	0.9405	0.9999	Trk receptor signaling mediated by the MAPK pathway	1796
1432	11	-6.9827965396343	11	0.9412	0.9999	RHO GTPases Activate NADPH Oxidases	1408
856	10	-6.71127540956274	10	0.9419	0.9999	Dermatan sulfate biosynthesis	398
582	54	-13.1885477850928	54	0.9436	0.9999	p53 pathway	1131
144	103	-17.9285969344973	103	0.9446	0.9999	Carbon metabolism	219
536	51	-13.3510929518753	51	0.9447	0.9999	Role of Calcineurin-dependent NFAT signaling in lymphocytes	1453
4	16	-8.21311652198423	16	0.9449	0.9999	CDP-diacylglycerol biosynthesis	239
1816	42	-12.1499807199474	42	0.9465	0.9999	Viral Messenger RNA Synthesis	1844
213	63	-17.2241900402461	63	0.9468	0.9999	Glycolysis / Gluconeogenesis	660
1226	19	-8.9606820111389	19	0.9481	0.9999	Mitophagy*	976
722	16	-8.58373493379488	16	0.9492	0.9999	CREB phosphorylation through the activation of CaMKII	336
69	16	-8.47848390997856	16	0.9493	0.9999	Hepatitis B virus (dsDNA)	714
1453	145	-31.9955286949959	145	0.9493	0.9999	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	1433
1033	11	-8.38321963776876	11	0.9495	0.9999	Glycoprotein hormones	662
510	58	-14.0898969553702	58	0.9502	0.9999	Notch signaling pathway (PID)	1078
1357	13	-9.06362502696111	13	0.9518	0.9999	Peptide hormone biosynthesis	1164
348	154	-21.1878627998515	154	0.952	0.9999	RNA transport	1452
331	86	-17.388610141843	86	0.9525	0.9999	Progesterone-mediated oocyte maturation	1259
59	15	-9.0071833097515	15	0.953	0.9999	the visual cycle I (vertebrates)	1701
1503	155	-21.0818533955467	155	0.9532	0.9999	Regulation of TP53 Activity	1365
227	13	-8.99326502144741	13	0.9538	0.9999	Guanine ribonucleotide biosynthesis IMP => GDP,GTP	690
1844	50	-13.9575406613719	50	0.9548	0.9999	mRNA Splicing - Minor Pathway	995
1011	64	-16.5968632619872	64	0.955	0.9999	Gap-filling DNA repair synthesis and ligation in TC-NER	622
1199	51	-14.9126124046279	51	0.9552	0.9999	Metabolism of non-coding RNA*	941
1143	18	-9.91418719647479	18	0.9554	0.9999	KSRP (KHSRP) binds and destabilizes mRNA	865
886	65	-17.0013618606805	65	0.9574	0.9999	Dual incision in TC-NER	448
929	13	-8.74806668650312	13	0.9577	0.9999	FCGR activation	541
103	34	-12.0939625878317	34	0.9579	0.9999	Alanine, aspartate and glutamate metabolism	72
341	162	-22.5320900766844	162	0.9588	0.9999	Purine metabolism (KEGG)	1281
369	43	-14.4029691802098	43	0.961	0.9999	Sphingolipid metabolism (KEGG)	1595
1079	20	-11.2961436697417	20	0.961	0.9999	IL-6-type cytokine receptor ligand interactions	767
704	17	-9.92975274261793	17	0.9634	0.9999	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	199
1096	137	-22.1391914706959	137	0.9635	0.9999	Influenza Life Cycle	790
291	15	-10.4142026605467	15	0.9638	0.9999	Nitrogen metabolism	1062
1533	34	-13.6200891310768	34	0.9642	0.9999	Resolution of D-Loop Structures*	1383
1471	66	-17.2900857917689	66	0.9653	0.9999	RNA polymerase II transcribes snRNA genes	1437
706	137	-25.24242811163	137	0.9654	0.9999	C-type lectin receptors (CLRs)	203
164	76	-22.7090367785686	76	0.966	0.9999	Complement and coagulation cascades	313
1767	35	-13.6774244849211	35	0.9666	0.9999	Transcriptional regulation of pluripotent stem cells	1762
215	19	-10.8274528792232	19	0.9669	0.9999	Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate	663
1056	11	-8.89451685213492	11	0.9699	0.9999	HSF1 activation	747
897	21	-11.0691978305948	21	0.9715	0.9999	ER Quality Control Compartment (ERQC)	494
367	136	-25.566309094144	136	0.9722	0.9999	Signaling pathways regulating pluripotency of stem cells	1576
1845	16	-10.3186875889454	16	0.9723	0.9999	mRNA decay by 3' to 5' exoribonuclease	990
1841	10	-9.6299328812934	10	0.9736	0.9999	mRNA Editing	992
1046	67	-19.1787043450026	67	0.9739	0.9999	HDR through Homologous Recombination (HRR)	699
1680	18	-11.5864299386487	18	0.9742	0.9999	Synthesis of PIPs at the Golgi membrane	1659
18	12	-9.80272727060885	12	0.9743	0.9999	dermatan sulfate biosynthesis	397
1016	812	-71.2492926988094	812	0.9752	0.9999	Generic Transcription Pathway	628
1102	21	-15.4839792524549	21	0.9752	0.9999	Initial triggering of complement	797
317	10	-9.11603616608219	10	0.9758	0.9999	Pentose phosphate pathway (Pentose phosphate cycle)	1162
136	65	-19.9973623166353	65	0.9764	0.9999	Biosynthesis of amino acids	188
1466	36	-15.4971250694396	36	0.9766	0.9999	RNA Polymerase III Transcription Initiation	1447
98	20	-13.340307559166	20	0.9775	0.9999	Adenine ribonucleotide biosynthesis, IMP => ADP,ATP	55
1057	23	-14.4094987223651	23	0.9781	0.9999	HSF1-dependent transactivation	748
1463	41	-16.6314414363997	41	0.9782	0.9999	RNA Polymerase III Abortive And Retractive Initiation*	1444
455	19	-12.2846389343493	19	0.9787	0.9999	E-cadherin signaling in keratinocytes	449
1684	26	-13.7094413693465	26	0.9793	0.9999	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	1645
1040	25	-16.3651114422754	25	0.9794	0.9999	Growth hormone receptor signaling	688
682	15	-12.9663987031181	15	0.9797	0.9999	Attenuation phase	148
181	191	-31.8689153925314	191	0.9803	0.9999	Epstein-Barr virus infection	493
1504	29	-15.2351033446046	29	0.9803	0.9999	Regulation of TP53 Activity through Acetylation	1366
1032	30	-15.6611154842873	30	0.9812	0.9999	Glycolysis	658
933	27	-15.7192791064844	27	0.983	0.9999	FGFR2 alternative splicing	548
1549	24	-14.9264571392728	24	0.983	0.9999	Role of phospholipids in phagocytosis	1455
1467	28	-15.5894843724745	28	0.9837	0.9999	RNA Polymerase III Transcription Initiation From Type 1 Promoter*	1448
283	13	-11.7902081749439	13	0.9842	0.9999	N-glycan precursor biosynthesis	1017
1840	29	-15.6231393100801	29	0.9862	0.9999	mRNA Capping	989
65	35	-23.4865023348326	31	0.9884	0.9999	Dengue Fever Virus (ssRNA)	392
640	56	-21.8213193516401	57	0.9885	0.9999	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S*	43
373	53	-35.6763782470707	53	0.9905	0.9999	Staphylococcus aureus infection	1605
969	48	-20.5656019490431	48	0.9907	0.9999	Formation of the ternary complex, and subsequently, the 43S complex	574
1052	44	-21.812019876739	44	0.9909	0.9999	HIV Transcription Initiation*	736
666	91	-65.3781907805133	91	0.9911	0.9999	Antimicrobial peptides	106
1022	76	-27.6077319731047	76	0.9913	0.9999	Glucose metabolism	640
1185	159	-34.4892043763919	159	0.9913	0.9999	Major pathway of rRNA processing in the nucleolus and cytosol	904
212	23	-18.6520270435926	23	0.9917	0.9999	Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate	659
24	13	-13.0494127956173	13	0.9925	0.9999	glycolysis	657
342	100	-30.8211675495611	100	0.9927	0.9999	Pyrimidine metabolism (KEGG)	1291
947	14	-15.4830795815026	14	0.9927	0.9999	Facilitative Na+-independent glucose transporters	517
1021	30	-19.4866290901815	30	0.993	0.9999	Gluconeogenesis	638
798	12	-18.3030033259639	12	0.9933	0.9999	Creation of C4 and C2 activators	335
782	43	-30.4260786066899	43	0.9934	0.9999	Complement cascade	314
1493	67	-26.5577990633695	67	0.9936	0.9999	Regulation of HSF1-mediated heat shock response	1338
832	28	-28.1245146723484	28	0.9939	0.9999	Dectin-2 family	372
1448	31	-20.1659607867498	32	0.994	0.9999	RNA Polymerase I Promoter Escape*	1428
752	85	-30.955943200528	85	0.9948	0.9999	Cellular response to heat stress	252
1444	27	-18.202142580579	27	0.9949	0.9999	RNA Pol II CTD phosphorylation and interaction with CE*	1423
1003	106	-33.2167477036127	107	0.995	0.9999	GTP hydrolysis and joining of the 60S ribosomal subunit*	689
68	149	-41.2118583013091	136	0.9952	0.9999	Epstein-Barr Virus (dsDNA)	492
964	96	-31.7581870899497	96	0.9954	0.9999	Formation of a pool of free 40S subunits	562
845	48	-82.8441052545383	48	0.9955	0.9999	Defensins	385
1860	174	-40.9064450800338	174	0.9956	0.9999	rRNA processing*	1459
22	13	-15.6106639607955	13	0.9961	0.9999	gluconeogenesis	637
205	15	-19.2865443662947	15	0.9964	0.9999	Gluconeogenesis, oxaloacetate => fructose-6P	639
692	39	-82.0606093005855	39	0.9966	0.9999	Beta defensins	175
347	30	-21.0621158132538	30	0.9968	0.9999	RNA polymerase	1425
734	113	-37.180840041808	113	0.9972	0.9999	Cap-dependent Translation Initiation*	217
1451	47	-29.7106537105595	47	0.9987	0.9999	RNA Polymerase I Transcription Initiation	1431
214	10	-23.4723029473937	10	0.9991	0.9999	Glycolysis, core module involving three-carbon compounds	661
1770	147	-48.394051168644	147	0.9992	0.9999	Translation	1765
252	53	-36.8066875708244	53	0.9995	0.9999	Legionellosis	873
1194	278	-81.3015950170803	278	0.9999	0.9999	Metabolism of carbohydrates	936
